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Abstract 
Objectives We sought to examine the gender differences between C - reactive protein  
  (CRP) and muscle strengthening activity (MSA) in U.S. adults (≥20 years  
  of age). 
Background Elevated levels of CRP have been shown to be associated with an increase 
  in risk of cardiovascular disease (CVD). Studies analyzing the relationship 
  between physical activity (PA) and CRP by gender have produced mixed  
  results. 
Methods The sample (n=9,135) included participants in the 1999-2004 National  
  Health and Nutrition Examination Survey (NHANES). Three categories of 
  reported MSA participation were created: no MSA (referent group), some  
  MSA (≥1 to <2 d/wk), and meeting the 2008 Department of Health  
  and Human Services (DHHS) recommendation (>2 d/wk). The   
  dependent variable was elevated CRP (>3 to 10 mg/L).  
Results Gender stratified analysis revealed significantly lower odds of having  
  elevated CRP for women reporting some MSA (OR 0.61; 95% CI 0.45- 
  0.83, P=0.0023), or volumes of MSA meeting the DHHS recommendation 
  (OR 0.66; 95% CI 0.54-0.82, P=0.0004). Significantly lower odds of men  
  having elevated CRP was observed in those reporting MSA volumes  
  meeting the recommendation (OR 0.73; 95% CI 0.61-0.88, P=0.0011).  
  Following adjustment for waist circumference (WC) these odds remained  
  significant in men but not women.  
xv 
 
Conclusions Women reporting any MSA were found to have lower odds of having  
  elevated CRP when compared to those reporting no MSA prior to   
  adjustment for WC. Significantly lower odds in men were only observed  
  in those meeting the recommendation. These results suggest that WC may  
  mediate the associations between MSA and CRP and this relationship may 
  be stronger in women.
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 C - reactive protein (CRP) is an acute phase protein synthesized by the liver and 
adipose tissue in response to inflammation (1-4). CRP levels measured by high sensitivity 
(hs)-CRP assays have shown efficacy in predicting risk of vascular events (5-7). Previous 
studies have found that CRP levels are associated with cardiorespiratory fitness levels 
and self-reported physical activity (PA) (8,9). This chapter provides an overview of CRP, 
discusses the current guidelines for clinical practice, and provides an abbreviated 
literature review. It concludes with the problem being addressed, the purpose of this 
research, and the operational definitions for the relevant terminology. 
 
Background 
Elevated levels of CRP, a non-specific marker of inflammation, have been shown to be 
associated with an increase in risk of cardiovascular disease (CVD) (1). Moreover, 
previous cross-sectional analyses have revealed significant positive associations between 
CRP concentration and self-reported myocardial infarction (10) and stroke (11). It has 
also been shown that PA participation has a role in reducing incidence of CVD (12). 
Interestingly, though PA may produce a short term rise in circulating levels of CRP, long 
term participation in exercise training has been shown to reduce CRP levels (13). Some 
studies have shown that the associations between PA and CVD may be mediated largely 
by inflammation (14,15).  
 
Prevalence of Elevated CRP 
Using data from NHANES 1999-2000, a nationally representative sample, Ajani et al. 
(16) found that approximately one in every four persons ≥20 years of age, without 
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coronary heart disease (CHD) or diabetes, and with serum lipid concentrations within 
recommended ranges, had a CRP concentration >3 to 10 mg/L (Table 1). The prevalence 
estimates of high CRP varied with body mass index (BMI), with approximately one-third 
of obese people, with lipid concentrations within recommended ranges and without CHD 
or diabetes, having high CRP concentrations. 
Table 1: Prevalence of high CRP concentrations (>3.0 mg/L) among persons with serum lipid 
concentrations within recommended ranges after exclusion of those with CRP >10 mg/L, NHANES 
1999–2000 
 Normal LDL-C1 Normal HDL-C1 Normal TC1 Normal lipid 
profile1 
All participants     
 Weighted percentage with concentrations 
within recommended ranges 
57.4% 75.9% 51.4% 34.2% 
 Median CRP concentrations, mg/L 1.7 1.6 1.4 1.2 
 Crude (SE) prevalence of high CRP, % 26.7 (1.9) 28.1 (2.2) 24.3 (1.9) 22.2 (2.4) 
 Adjusted (SE)2 prevalence of high CRP, %  27.3 (1.9) 27.3 (2.2) 25.8 (2.0) 22.9 (2.5) 
 Estimated no. with high CRP 26 900 632 37 538 753 21 915 520 13 363 660 
Persons without CHD and diabetes mellitus     
 Weighted percentage with concentrations 
within recommended ranges 
57.1% 77.2% 51.3% 35.1% 
 Median CRP concentrations, mg/L 1.7 1.6 1.4 1.1 
 Crude (SE) prevalence of high CRP, % 26.2 (2.0) 27.5 (2.2) 24.0 (2.1) 22.1 (2.7) 
 Adjusted (SE)2 prevalence of high CRP, %  27.1 (2.0) 26.6 (2.2) 25.9 (2.2) 23.1 (2.7) 
 Estimated no. with high CRP 23 577 949 33 359 076 19 336 181 12 243 745 
Stratified by body mass index     
 Normal (<25.0 kg/m2)      
  Crude (SE) prevalence of high CRP, % 15.9 (2.4) 16.0 (2.3) 12.7 (2.5) 13.0 (2.7) 
  Adjusted (SE)2 prevalence of high CRP, %  17.2 (2.2) 16.0 (2.2) 14.7 (2.5) 14.4 (2.7) 
  Estimated no. with high CRP 6 980 415 9 474 718 5 067 842 4 060 391 
 Overweight (25.1 to <30.0 kg/m2)      
  Crude (SE) prevalence of high CRP, % 30.3 (3.8) 30.9 (3.3) 28.4 (4.0) 30.9 (5.8) 
  Adjusted (SE)2 prevalence of high CRP, %  30.9 (4.1) 29.8 (3.4) 30.3 (4.3) 31.6 (5.8) 
  Estimated no. with high CRP 8 291 472 11 480 752 7 070 541 4 619 161 
 Obese (≥30 kg/m2)      
  Crude (SE) prevalence of high CRP, % 44.6 (4.3) 49.7 (4.0) 44.9 (4.7) 38.9 (5.8) 
  Adjusted (SE)2 prevalence of high CRP, %  43.0 (3.9) 46.1 (4.1) 44.1 (4.3) 36.0 (5.1) 
  Estimated no. with high CRP 8 306 062 12 403 606 7 197 798 3 564 194 
Note. Adapted from “Prevalence of high C - reactive protein in persons with serum lipid concentrations 
within recommended values” by Ajani et al. Clin Chem 50(9):1618-22, 2004. Copyright 2014 by the 
American Association for Clinical Chemistry. 
 
In a study investigating associations between cardiorespiratory fitness levels and 
elevated CRP (≥2 mg/L), Church et al. (8) found fitness levels to be inversely associated 
with elevated CRP values in men participating in the Aerobics Center Longitudinal Study 
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(ACLS), independent of BMI (figure 1). These investigators revealed a significant 
inverse trend in the prevalence of elevated CRP across fitness quintiles (P<0.0001). In 
comparison to men in the lowest fitness quintile, all other fitness quintiles had 
significantly lower odds of having elevated CRP, with the lowest odds of high CRP being 
found in the highest fitness category, odds ratio (odds ratio [OR] 0.17, 95% confidence 
interval [CI] 0.08 - 0.37; P=0.001). The OR for men having elevated CRP in the lowest 
fitness quintile compared with all other quintiles was 3.2 (95% CI 1.8 - 5.8; P<0.0001). 
The prevalence of elevated CRP across fitness quintiles, low to high, was 48%, 27%, 
24%, 22%, and 15% (P for trend <0.0001). 
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Figure 1: Data from 722 men in the ACLS. Data were adjusted for age, BMI, vitamin use, statin medication 
use, aspirin use, the presence of inflammatory disease, CVD, diabetes, and smoking. The top panel presents 
adjusted geometric mean CRP values across fitness quintiles, the middle panel depicts the percentage of 
individuals with a high CRP (≥2.0 mg/L) across fitness quintiles, and the bottom panel presents the odds of 
having high CRP across fitness quintiles, with the lowest quintile as the referent group. Error bars represent 
95% CIs. 
 
Note. Adapted from “Associations between cardiorespiratory fitness and C - reactive protein in men” by 
Church et al.  Arterioscler Thromb Vasc Biol 22(11):1869-76, 2002. Copyright 2002 by the American 
Heart Association. 
 
In a study using data from 15,341 male and female participants in NHANES III, 
Miller et al. (17) investigated the prevalence of high CRP using CHD risk factor cut 
points. Investigators in this study reported an overall prevalence of 25.7% for high CRP. 
Results of this study showed higher levels of CRP for blacks as well as markedly higher 
prevalence’s of high CRP with higher blood pressure, glucose levels, and BMI. Also, 
high CRP levels were more common in both former and active cigarette smokers when 
compared to those who had never smoked.  
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In comparison to a non-smoker referent group with no CHD risk factors, the 
presence of at least one borderline or abnormal CHD risk factor was associated with 
approximately three fold higher prevalence of CRP levels >3 mg/L. The prevalence of 
elevated CRP was also higher among postmenopausal women receiving hormone 
replacement therapy when compared to nonusers and former users, 51% versus 37%, 
respectively. Moderate and/or vigorous PA was not included in analysis. The risk of 
elevated CRP levels attributable to the presence at least one abnormal or borderline CHD 
risk factor was found to be approximately 78% for men and 67% for women (17). 
 
Current Clinical Practice Recommendations 
In a statement issued for healthcare professionals from the Centers for Disease Control 
and Prevention (CDC) and the American Heart Association (AHA) (18), clinical 
applications and health practice questions regarding CRP assay use and risk level cut 
points are addressed. Standard CRP assays have lower detection limits of 3-8 mg/L. 
Since these assays lacked the sensitivity to accurately measure CRP ranges within the 
low to normal range, they could not be employed in cardiovascular risk prediction 
research. This limitation prompted epidemiological studies to begin using assays 
designed to determine CRP levels across the normal range. These assays are referred to 
as "high-sensitivity" (hs) or "ultra-sensitive" assays, which are now commercially 
available (19).  
 Thus, the use of the hs-CRP assay for CRP measurement is currently 
recommended. This recommendation is due to hs-CRP analyte precision, accuracy, and 
availability. The hs-CRP assay should only be performed on apparently healthy people 
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not displaying signs of acute inflammation and assay results should be expressed as 
milligrams per liter (mg/L). The average of two assays, two weeks apart, should be used 
to provide the most stable CRP estimate; a fasting state is not required. Lastly, since CRP 
levels of 10 to 40 mg/L are associated with mild inflammation, and levels of 40 to 200 
mg/L with an acute inflammation and bacterial infection, CRP levels >10 mg/L should be 
considered due to acute inflammation and discarded from analysis (6,7,18,20).  
 The recommended CRP level cut points for clinical use (Table 2) are <1.0 mg/L 
for low risk, 1.0-3.0 mg/L for average risk, and >3.0 mg/L for high risk, with the high 
risk tertile cited as having approximately two-fold increase in relative risk of CVD when 
compared with the low tertile (18). These tertiles were based on the distributions of hs-
CRP from >15 populations, >40 000 people, collected for the purpose of defining the 
population distribution. Largely, the high risk hs-CRP category included the skewed tail 
of the distribution (18). The cost of CRP screening has been compared to that of standard 
cholesterol testing and by adding CRP to LDL-C screening there stands the potential for 
an immediate cost savings and circumvention of additional and unnecessary testing (6).  
Table 2: CDC and the AHA Recommendations for Use of Inflammatory Markers in 
Clinical and Public Health Practice 
Cardiovascular Risk Level Laboratory Value (hs-CRP, mg/L) 
Low <1 
Average 1-3 
High >3 
Note. Adapted from “Markers of Inflammation and Cardiovascular Disease Application to Clinical and 
Public Health Practice; A Statement for Healthcare Professionals from the Centers for Disease Control and 
Prevention and the American Heart Association” by Pearson et al. Circulation 107(3):499-511, 2003. 
Copyright 2003 by the American Heart Association. 
 
Abbreviated Literature Review 
Though some studies have shown that participation in various forms of muscle 
strengthening activity (MSA) is associated with lower circulating levels of CRP, the 
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study populations have been small and not representative of the U.S. population (21-23). 
Moreover, when stratified by gender, studies analyzing the distribution of elevated CRP 
(>3 mg/L), or the relationship between PA and CRP, have produced mixed results and 
the implications remain unclear (24-29).  
 
Purpose and Research Questions 
The purpose of this study was to examine the associations between self-reported MSA 
and CRP in adult participants of the NHANES when stratified by gender. Emphasis was 
placed on determining whether volumes of MSA meeting the 2008 Department of Health 
and Human Services (DHHS) recommendation (30) are associated with significantly 
lower odds of elevated CRP and examining the mediating effects of central adiposity on 
this association. The specific research questions addressed by this study are as follows:    
1. Is there an association between volumes of MSA meeting the current DHHS 
recommendation and having an elevated CRP level? 
2. If a relationship does exist, is that relationship different for each gender? 
3. Does waist circumference (WC) mediate this relationship? 
 
 To the extent of our knowledge, this is the first study to examine the potential 
gender differences in high sensitivity measured CRP levels and volumes of MSA in 
adults aged ≥20 years in NHANES 1999-2004. Ultimately, this study adds to the 
evidence demonstrating gender specific associations between MSA and cardio-metabolic 
risk. 
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Project Description 
For this study, the sample was limited to adults (≥20 years of age).  Participants who 
attended a mobile examination center (MEC) in the 1999-2004 NHANES were included 
in the resultant analyses.  Pregnant women were excluded from the analyses. Lastly, the 
participants included in the analyses had complete data on all the variables of interest. 
The present study has several inherent limitations due to the design. Consequently, all 
findings must be interpreted with caution.  These limitations are as follows: 
1. The most recent NHANES MSA data were collected from 1999-2004. Therefore 
the analyzed data may not be reflective of the current U.S. adult population.   
2. Due to the nature of the cross-sectional study design, causality will not be able to 
be established. 
3. The MSA data was self-reported over the past 30 days; as a result the frequency 
of MSA is subject to recall bias. 
4. The MSA data is not objectively measured 
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 C - reactive protein (CRP) is regarded as a marker of acute phase inflammation 
and chronic low-grade inflammation and has shown value as a predictor of future risk for 
cardiovascular disease (CVD) (1,2). The levels described as low grade systemic 
inflammation have been previously characterized by a two-to-threefold increase in 
concentrations of CRP (3). Evidence suggests that elevated CRP levels are predictive of 
myocardial infarction (MI), stroke, peripheral arterial disease (PAD), and sudden cardiac 
death (4). Risk of CVD has also been shown to increase with increased leisure-time 
sedentary behavior (LTSB), such as increased screen time, and decrease with 
participation in vigorous activity. These studies revealed increased mortality and CVD 
risk regardless of physical activity participation, thus warranting further analysis using 
population based reports of LTSB and the associations with CRP. 
The following literature review will discuss 1) the history, structure, and 
production of CRP; 2) a brief summary of the relationship between CRP and 
atherosclerosis; 3) a concise explanation of the relationship between myocytes and CRP 
production; 4) concise reviews of the previous studies examining the associations 
between MSA and CRP.  
 
CRP: Discovery, Structure, and Production  
CRP was discovered in 1930 at the Rockefeller Institute for Medical Research by 
William S. Tillet and Thomas Francis in the serum of patients with acute inflammation 
due to streptococcus pneumonia infection (5).  Serum obtained from these patients during 
the acute phase response of the infection was found to contain a protein, at first referred 
to as “fraction C”, that could precipitate the “C” polysaccharide derived from the 
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pneumococcal cell wall. Following this discovery in 1941, Oswald T. Avery and 
Theodore J. Abernethy would find that the substance that was responsible for the 
precipitation with fraction C was a protein, thus dubbed CRP, with calcium being 
essential to the reaction (6,7). 
 CRP plays a role in the innate immune system by activating the classical 
complement pathway. Through the calcium dependent binding of ligands containing 
phosphocholine, as well to the phospholipids of damaged cells, CRP enhances the uptake 
of damaged cells by macrophages (8,9). Initially, CRP was considered a pathogenic 
secretion elevated in people suffering from one of many forms of tissue damage (10). 
However, synthesis by hepatocytes demonstrates that CRP is a native protein. At the 
transcriptional level, CRP is regulated by the cytokine interleukin (IL)-6 and enhanced 
IL-1, with tumor necrosis factor (TNF)-α possibly playing a part in CRP synthesis 
through influencing IL-6 production (6,11).  
CRP is a protein of the pentraxin family. It consists of five non-covalently bound 
identical protomers arranged around a central pore. Each protomer subunit consists of a 
single polypeptide chain of 206 amino acids with a total molecular weight of 
approximately 23,000 Dalton (Da). Each subunit has two calcium ions surrounding a 
hydrophobic pocket, thus making it capable of forming calcium-dependent bonds with 
ligands, usually phosphocholine (PCh). The above described Fraction C, present on the 
bacterial cell wall, contains phosphocholine (6,7). It is a non-glycosylated protein and the 
gene has been mapped to chromosome 1 (12). 
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CRP and Atherosclerosis  
C - reactive protein has been shown to possess several properties that make it capable of 
increasing atherosclerosis. C - reactive protein has been shown to increase the expression 
adhesion molecules by endothelial cells.  Additionally, CRP has been shown to bind to 
and enhance the uptake of oxidized low-density lipoprotein cholesterol (LDL-C) by 
macrophages (6,8), a process which some investigators have concluded enhances foam 
cell formation (13). Furthermore, CRP has been shown to decrease the bioavailability of 
endothelial nitric oxide synthase (eNOS), a protein expressed in response to shear stress 
for the purpose of enhancing vascular tone in endothelial cells (14).  
Correlations between elevated CRP and coronary heart disease (CHD) have been 
demonstrated in cross-sectional and prospective population studies including the 
Women’s Health Study and the Third National Health and Nutrition Examination Survey 
(NHANES) 1988-94 (15-17). In a prospective analysis of 28,263 women who 
participated in the Women’s Health Study, Ridker et al. (17) found high-sensitivity (hs)-
CRP was a stronger predictor of the risk of cardiovascular events than other markers 
associated with cardiovascular events:, the relative risk of the highest compared with the 
lowest quartile for this marker was 4.4 (95% confidence interval [CI]:2.2-8.9). The 
studies using data from the Third NHANES found that among children and young adults, 
CRP levels were directly correlated with body mass index (BMI) and waist-to-hip ratio 
(16,18).  
These findings bolster evidence from other studies demonstrating IL-6 and TNF-α 
production by adipocytes (11,19). In an arterio-venous difference study of 39 male and 
female participants, concentrations of IL-6 increased with adiposity, with an estimated 
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15-35%, depending on time of day, of the circulating concentrations of IL-6 in healthy 
subjects originating from adipocytes (19). Similarly, in a cross-sectional analysis of 39 
male and female subjects (11), levels of CRP were found to be significantly related to 
levels of IL-6 (r=0.37, P<0.0005) and TNF-α (r=0.46, P<0.0001). 
 
Myocytes and CRP 
C - reactive protein concentrations are largely determined by upstream production of the 
cytokine IL-6 (20). In a 2007 review examining the role of myokines in exercise and 
metabolism, Pedersen et al. (21) noted that the magnitude of increase in IL-6 during 
exercise is related to duration, intensity, the amount of muscle mass involved, and 
endurance capacity. However, investigations of this cytokine have produced mixed 
results about the anti- or pro-inflammatory nature of this cytokine (22). Evidence has 
shown that IL-1ra and IL-10, both considered anti-inflammatory cytokines, will increase 
in response to exercise induced IL-6 production (3). Interestingly, some studies have also 
suggested that IL-6 produced by myocytes, which are also often referred to as muscle 
cells or muscle fibers, appears to produce an anti-inflammatory response (23). This 
contrasts with IL-6 production by adipocytes, which appears to be associated with 
chronic pro-inflammatory production of IL-6 (23). Interleukin-6 produced by myocytes 
during exercise has also been previously shown to increase the production of IL-10 and 
IL-1ra and decrease the production of TNF-α and IL-1β (22,24). Thus, evidence now 
suggests that in response to exercise, myocytes may produce anti-inflammatory IL-6. 
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Analysis of Individual Studies 
In a 2010 review by Beavers et al. (25), the effects of exercise training on chronic 
inflammation were summarized. In this review, several observational studies 
demonstrated inverse associations between self-reported PA or fitness and CRP 
independent of obesity. However, studies utilizing a resistance training (RT) intervention 
have produced mixed results. The following sections will discuss 1) studies that reported 
significant reductions in CRP when implementing a RT intervention (Table 1); 2) those 
studies that found no significant reductions when implementing a RT intervention (Table 
2); and lastly 3) those examining gender and ethnicity differences in the distribution of 
CRP. 
 
Studies Reporting Lower CRP with RT   
In a 2003 study examining the relationship between inflammatory markers and exercise 
in 4,072 adult (≥17 years of age) participants in the Third NHANES, King et al. (33) 
reported inverse associations between reporting participation in various forms of exercise 
and having an elevated CRP level (>3 mg/L).  These investigators compared the CRP 
levels of non- and infrequent exercisers (0-11 times/mo.) to those who engage in regular 
exercise (≥12 times/mo.). Analysis revealed significantly (P<0.05) lower likelihood of 
elevated CRP among those reporting participation in physical activities, which included 
weight lifting and calisthenics, when using non- and infrequent exercisers (0-11 
times/mo.) combined as the referent group. However, following adjustments for 
covariates that included age, race/ethnicity, gender, BMI, smoking, and health status, this 
association remained significant only in those reporting jogging or aerobic dancing.  
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In contrast to the above-mentioned representative sample of adults, some 
investigators have studied disease-specific populations. For example, in 2006 White et al. 
(26) sought to examine whether RT in individuals with multiple sclerosis (MS) would 
significantly improve immune function. These investigators recruited 10 overweight 
(BMI=26.0 ± 7.0 kg/m2) middle aged (47.0 ± 12.0 yr) female MS patients to participate 
in eight weeks of progressive RT (five exercises, one set, six to 15 repetitions, and two 
d/wk.). Pre- and post-training measurements of serum concentrations of cytokines that 
included CRP were taken. Following training, resting CRP levels (mg/L) were 
significantly reduced (before, 4.8 ± 1.7 vs. after, 3.4 ± 1.0; P=0.007) with no change in 
estimated body fat using a three-site skinfold measurement of subcutaneous fat (triceps, 
thigh, suprailium). These investigators suggested that a progressive RT program may 
have a significant beneficial impact on CRP concentrations in overweight women with 
MS. 
In a study citing how little is known about the effects of RT on inflammatory 
biomarkers, Olson et al. (27) examined the effects of a one-year moderate intensity RT 
program in healthy overweight (BMI=27.0 ± 3.0 kg/m2) adult (38.5 ± 5.5 yr) women. The 
28 women included in this study were assigned to either a control (n=12) or RT group 
(n=16). Measures were taken at baseline and following one year of RT. These 
investigators reported no differences at baseline or following the intervention for change 
in body mass, BMI, fat mass or percent body fat using dual-energy x-ray absorptiometry 
(DXA). There was, however, a significant increase in lean body mass in the intervention 
group (P<0.05). Interestingly, no changes were demonstrated in IL-6, a known upstream 
determinant for increased CRP production, but significant reductions were noted for CRP 
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(P<0.01) in the RT group. This study demonstrates the beneficial effects of RT on CRP 
levels in overweight women. 
Other investigators have chosen to focus on specific ethnicities. For example, 
Brooks et al. (28) sought to examine whether or not RT would be an effective addition to 
a lifestyle intervention designed to influence variables that included CRP levels. The 
participants included 62 Hispanic older (66 ± 1.5 yr) obese (BMI=31.1 ± 1.1 kg/m2) 
adults identified as community-dwelling with type 2 diabetes (T2D). Participants were 
randomized into a RT plus standard care group (n=31) or a standard care only control 
group (n=31) for 16 weeks. Measures were taken at baseline and again at 16 weeks. The 
RT group showed significant reductions in median CRP levels [RT: median CRP,-1.3 
(interquartile range, 2.9) mg/L vs. Controls: 0.4 (2.3) mg/L, P=0.05]. Any changes in 
measures of adiposity went unaddressed by the study authors. In this group of older 
Hispanic adults with T2D, RT significantly improved CRP levels.   
In contrast, the results from a study of young African American and White 
American male subjects produced mixed results. Heffernan et al. (29) reported that in a 
sample of 44 young (22.0 ± 1.0 yr) overweight (BMI=27.3 ± 1.2 kg/m2) males, six weeks 
of RT (five to six exercises, three sets, eight to 15 rep maximum, three d/wk.) resulted in 
a significant (P<0.05) decrease in CRP levels (mg/L) in only African American subjects, 
a decrease that remained significant following a four week detraining period (CRP at 
baseline; 4.84 ± 0.9, following six weeks of training; 2.34 ± 0.5, and following four 
weeks of detraining; 1.91 ± 0.4). There were no significant changes in body fat for any 
study participants. No significant reductions in CRP were observed in the white study 
participants. 
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In a study that combined both genders, Donges et al. (30) investigated the effects 
of 10 weeks of exercise training on CRP in a sample of male (n=45) and female (n=57) 
overweight (BMI=28.7 ± 4.5 kg/m2) sedentary subjects (ages not provided). Subjects 
were assigned to a RT group (n=35), an aerobic training (AT) group (n=41), or a control 
group (n=26) that remained sedentary. Interestingly, only the RT protocol resulted in a 
significant (P<0.05) attenuation of CRP levels, (CRP at baseline, 3.57 ± 2.08 mg/L, 
following training 2.40 ± 2.03 mg/L) a 32.8% reduction.  In this study, the AT group 
demonstrated significant (P<0.05) reductions in measures of adiposity when compared to 
the RT group, including body mass, BMI, and DXA measured intra-abdominal fat mass. 
Given the resultant lack of change in adiposity in the RT group, these authors have 
suggested that an alteration in body composition, while beneficial, may not be necessary 
to reduce CRP. 
 In a similarly designed study, Martins et al. (31) investigated the effects of 
different exercise programs on CRP levels in 45 overweight (BMI=29.6 ± 4.5 kg/m2) 
elderly (76.9 ± 7.3 yr) men (n=18) and women (n=27) randomly assigned to one of two 
16 week exercise intervention groups, AT or RT, or a non-exercising control group. The 
training period was followed by a 16 week detraining period. Measures were taken at 
baseline and at the 16 and 32 week end points. These investigators reported a 10 and 51% 
decrease in CRP at 16 and 32 weeks for the AT group, respectively. In comparison, CRP 
levels decreased 11 and 39% in the RT group at the 16 and 32 week end points, 
respectively. The reductions in CRP were significant for both intervention groups at the 
32 week end point when compared to baseline measures. Interestingly, no significant 
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changes were noted in the RT group for BMI. However, waist circumference (WC) 
significantly increased from week 16 to 32.  
Using another elderly cohort, Ogawa et al. (32) investigated the impact of 12 
weeks of low-intensity RT on CRP levels in 21 elderly women (85.0 ± 4.5 yr) with 
desirable BMI levels (BMI=21.2 ± 4.0 kg/m2). C - reactive protein was among several 
biomarkers being measured to assess improvements in levels of inflammation at baseline 
and following the training period. This study did not utilize a control group. However, in 
comparison to baseline measures of CRP (2.44 ± 3.22), RT resulted in significantly 
reduced CRP levels (1.46 ± 2.22, P<0.05). These reductions were also reported to be 
significantly (P<0.01) associated with increased muscle thickness (r=-0.61). No 
significant changes were noted for body weight (kg), BMI, or WC. None of the results 
were significant after applying a Bonferroni correction. Thus, there is evidence 
suggesting RT interventions lead to improvements in CRP levels in women. 
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Table 1. Trials Reporting Significant Reductions in CRP with RT 
Author  
(Year) N 
Subjects  
Age (Years) Duration 
RT 
Intervention 
RT BMI (kg/m2) 
Before         After 
RT CRP (mg/L) 
Before              After 
White et al.(26) 
(2006) 
10 
Uncontrolled 
overweight 
women w/ MS 
47.0 ± 12.0 
8 wk.; 
2 d/wk. 
1 set; 
5 exercises; 
6-15 reps; 
50-10% MVC 
26.0 ± 7.0 n/a  4.8 ± 1.7  3.4 ± 1.0 P=0.007 
Olson et al.(27) 
(2007) 
28 
(CG=12) 
(RT=16) 
overweight 
women 
38.5 ± 5.5 
1 yr.; 
2 d/wk. 
3 sets; 
9 exercises; 
8-10 reps; 
8RM 
26.9 ± 3.0 27.5 ± 3.8  3.3 ± 0.4  3.0 ± 0.4 P<0.01 
Brooks et al.(28) 
(2007) 
62 
(CG=31) 
(RT=31 
obese Hispanic 
men w/ T2D 
66 ± 1.5 
16 wk.; 
3 d/wk. 
3 sets; 
5 exercises; 
8 reps; 
60-80% 1RM 
30.9 ± 1.1 n/a 3.5 (9.1)a 
 
2.8 (2.8)a 
P=0.05 
Heffernan et al.(29) 
 (2009) 
44 
Uncontrolled 
overweight 
men 
22.0 ± 1.0 
6 wk.; 
3d/wk. 
3 sets; 
5-6 exercises; 
8-15RM 
27.3 ± 1.2 n/a 
 
AA, 
4.84(0.9) 
 
WA,  
1.34(0.9) 
AA,  
2.34(0.5) 
P<0.05 
 
WA,  
1.70(0.5) 
P>0.05 
Donges et al.(30) 
(2010) 
102 
(CG=26) 
(RT=35) 
(AT=41) 
overweight 
men and 
women 
(age n/a) 
10 wk.; 
3d/wk. 
 
2-4 sets; 
5-7 exercises; 
8-10 reps; 
70-75% 1RM 
27.8 ± 3.9 28.1 ± 4.0 3.57 ± 2.08 2.40 ± 2.03 P<0.05 
Martins et al.(31) 
(2010) 
45 
(CG=13) 
(RT=14) 
(AT=18) 
obese 
men and 
women 
76.9 ± 7.3 
16 wk.; 
3d/wk. 
 
16 wk. 
detraining 
1-3 sets; 
8 exercises; 
8-15reps 
30.8 ± 5.3 
16 wk.; 
30.3 ± 5.2 
 
32 wk.; 
30.6 ± 5.5 
 5.61 ± 4.12 
16 wk.;  
5.02 ± 3.85 
 
32 wk.; 
3.40 ± 2.85 
P<0.05 
Ogawa et al.(32) 
(2011) 
21 
Uncontrolled 
 women  
85.0 ± 4.5 
12 wk.; 
≥1d/wk. 
1-2sets; 
4 exercises; 
10reps 
21.2 ± 4.0 21.3 ± 3.8  2.44 ± 3.22  1.46 ± 2.22 P<0.05 
Abbreviations: kg=kilograms; m=meters; hr.=hours; d=day; wk.=week; mo.=month; CRP=C - reactive 
protein; CG=control group; RT=resistance training; AT=aerobic training; MVC=maximal voluntary 
contraction; RM= repetition maximum; BMI=body mass index; yr = years; T2D=Type 2 Diabetes; MS= 
Multiple Sclerosis; AA=African American; WA=White American 
values expressed as mean ± SD or mean (SE) 
a median (Interquartile Range) 
 
Studies Reporting No Change in CRP with RT   
A 2006 study by Klimcakova et al. (34) examined whether RT in obese (BMI=33.6 ± 1.2 
kg/m2) adult (50.4 ± 2.3 yr) males (n=12) is associated with changes in levels of 
adipokines that may be involved in development of insulin resistance. Blood samples 
were taken at baseline and following three months of RT. Body weight remained 
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unchanged during training. Study results revealed no significant changes in plasma levels 
of adipokines or CRP. In this small group of obese male subjects, RT resulted in 
improved insulin sensitivity; however, this change was not associated with any 
corresponding reduction in CRP.  
Kohut et al. (35) hypothesized that a long-term exercise intervention among older 
male and female adults would reduce inflammatory cytokines such as CRP, and that this 
potential reduction would be mediated, in part, by improvements in psychosocial factors 
and possibly adrenergic receptor mechanisms. Adults (≥64 yr) were randomized into 
either an AT group or a flexibility/strength exercise treatment group. The protocol 
required participation three d/wk, 45 min/day, for 10 months. These investigators 
reported significant reductions in serum CRP, IL-6, and IL-18 in those assigned to the AT 
group when compared to the flexibility/strength treatment group. 
 Overtraining protocols using younger male subjects have also failed to reveal 
significant reductions in CRP. Peake et al. (36) recruited 10 healthy young men who 
reported not being involved in a RT program and compared the changes in markers of 
muscle damage and systemic inflammation following submaximal and maximal 
lengthening muscle contractions of elbow flexors. The submaximal training required 10 
sets of 60 lengthening contractions at 10% maximum isometric strength with one-minute 
of rest between sets. The maximal training required 10 sets of three lengthening 
contractions at 100% maximum isometric strength with three minutes of rest between 
sets. The contractions were performed using an isokinetic dynamometer. The trials were 
separated by a minimum of two weeks and opposite arms were used for each trial. 
Venous blood samples were drawn before the trial, immediately after, at one hour and 
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three hours following completion, and one to four days following each trial. Following 
both trials, CRP remained unchanged. Interestingly, it was reported that there were no 
differences in markers of inflammation when comparing the trials, even though greater 
muscle damage was reported following maximal versus submaximal contractions. 
 In a trial designed to evaluate progressive RT, Misra et al. (37) recruited 30 (22 
male, 8 female) Asian Indian adults (40.8 ± 8.1yr) with T2D. These subjects participated 
in a 12 week RT program focused on six muscle groups (biceps flexion, shoulder flexion, 
finger grip, hip flexion, knee extension, and heel raise) implementing two set, 10 
repetition protocols. No significant changes were noted in CRP levels. However, this 
moderate-intensity three month RT protocol did result in significant improvement in 
markers that included insulin sensitivity, glycemia, and lipids. 
 In other highly disease-specific populations, AT and RT interventions have 
revealed mixed results on CRP levels. Utilizing biomarkers in subjects infected with 
Human Immunodeficiency Virus, Lindegaard et al. (38) evaluated the effects of RT and 
AT on insulin sensitivity and fat distribution. Subjects for this study included 20 HIV-
infected men, who were randomly assigned to RT (n=10) or AT (n=8, 2 withdrew) three 
times/wk for 16 weeks. The RT consisted of eight exercises (leg curl, pull-down, seated 
leg press, chest press, seated rows, leg extension, abdominal crunch, and back extension) 
using LifeFitness RT machines for 45–60 minutes. Results revealed significant (P<0.05) 
reductions in CRP concentrations only for those assigned to the AT group.  
 In a study noting that inflammatory markers like CRP, hepatic enzymes, and 
physical inactivity are often associated with the metabolic syndrome (39), Levinger et al. 
(40) examined whether these markers are correlated with risk factors for metabolic 
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syndrome by studying the effects of RT in individuals with a high number of metabolic 
risk factors (2.9 ± 0.8) and those with a low number (0.5 ± 0.5). This study included 28 
male and 27 female adults (50.8 ± 6.5 yr). Blood samples were obtained at baseline and 
following 10 weeks of RT. The study protocol included three sets of seven exercises 
(chest press, leg press, lateral pull-down, triceps push-down, knee extension, seated row 
and biceps curl) three d/wk.. Intensity was gradually increased from 40-50% to 75-85% 
of one repetition maximum (1RM=largest load that an individual can lift or move in a 
single effort). At baseline, those with a high number of metabolic risk factors had 
significantly (P<0.05) higher levels of IL-6 (33.9%) and CRP (57.1%) when compared 
with those with a low number of risk factors. Resistance training did not significantly 
change any of the inflammatory markers being studied. Though a high number of 
metabolic risk factors were associated with significantly increased levels of CRP, RT 
failed to reduce these levels. 
 In a study designed to examine different types of training and inflammatory 
markers, Libardi at al. (41) evaluated the effects of 16 weeks of RT, AT, or concurrent 
training (CT) on CRP levels and functional capacity in sedentary middle-aged men. 
Following randomization, subjects performed three weekly sessions lasting 
approximately one hour for 16 weeks. Maximal strength was tested using the bench press 
and leg press. Though maximal strength was increased following the 16 week training 
period, there were no significant differences in CRP when comparing measures collected 
at baseline to those at the study conclusion for any of the three assignment groups. 
 Swift et al. (42) also noted that though AT has been shown to improve CRP, there 
remains limited data evaluating other training modalities, such as RT or training that 
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combines RT and AT. Participants recruited for the purpose of investigating these 
different types of training included 204 older male and female adults with T2D (42). 
Subjects were randomized to an AT, RT, or a CT group for nine months. Participants in 
the RT group exercised three d/wk and completed two sets, 10 to 12 reps, of four upper 
body exercises (bench press, seated row, shoulder press, and lat pull down), three sets of 
three leg exercises (leg press, extension, and flexion), and two sets of abdominal crunches 
and back extensions. Concentrations of CRP were evaluated at baseline and at follow-up. 
Similar to the previously described study by Libardi et al. (41), CRP was not significantly 
reduced for any of the training modalities when compared to controls.  
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Table 2. Trials Reporting No Significant Reductions in CRP with RT 
Author  
(Year) N 
Subjects  
Age (Years) Duration RT Intervention 
RT BMI (kg/m2) 
Before          After 
RT CRP (mg/L) 
Before             After 
Klimcakova et al.(34) 
 (2006) 
12 
Uncontrolled 
obese men  
50.4 ± 2.3 
12 wk.; 
3d/wk. 
1 set; 
17 exercises; 
12-15 reps; 
60-70% 1RM 
33.6 ± 3.9 33.7 ± 4.0  3.3 ± 2.2  2.9 ± 1.7 
Kohut et al.(35) 
(2006) 
87 
RT=47 
AT=40 
overweight men 
and women 
70.1 ± 5.1 
10 mo.; 
3d/wk. 
10-15 reps; self-
directed using 
various machines 
29.3 ± 0.8 29.0 ± 0.8 > 4.0 ≈ 3.5 to 4.5 
Peake et al.(36) 
(2006) 
10 
Crossover 
Design 
men  
22.9 ± 4.7 4d. 
Submax; 
10 sets; 
60 reps; 
10 % MIS 
Max; 
10 sets; 
3 reps; 
100% MIS 
n/a n/a 
Submax; 
0.2 ± 0.3 
 
Max; 
0.5 ± 0.7 
 
Submax; 
0.5 ± 1.3 
 
Max; 
0.5 ± 0.8 
 
Misra et al.(37) 
(2008) 
30 
Uncontrolled 
men and women w/ 
T2D 
40.8 ± 8.1 
12wk.; 
3d/wk. 
2 sets; 
6 exercises; 
10 reps; 
24.1 ± 3.9 24.1 ± 3.7 n/a n/a 
Lindegaard et al.(38) 
(2008) 
33 
CG=15 
RT=10 
AT=8 
men w/ HIV 
 (n=18) 
Healthy CG 
(n=15) 
(age n/a) 
16 wk.; 
3d/wk. 
3-4 sets; 
8 exercises; 
8-12 reps; 
50-80% 1RM 
23.4 ± 2.5 n/a 1.54  (1.0-2.37)a 
0.11  
(0.18-0.35)c 
Levinger et al.(40) 
(2009) 
55 
HiMFT=15 
HiMFC=15 
LoMFT=12 
LoMFC=13 
men and women 
50.8 ± 6.5 
10 wk.; 
3d/wk. 
3 sets; 
7 exercises; 
 8-20 reps; 
40-85% 1RM 
n/a n/a 
HiMF 
2.8 ± 1.7 
LoMF 
1.2 ± 1.0 
 
HiMFT 
0.3 ± 2.5b 
HiMFC 
1.2 ± 3.7b 
LoMFT 
0.4 ± 0.9b 
LoMFC 
-0.2 ± 0.7b 
Libardi et al.(41) 
(2011) 
47 
RT=11 
AT=12 
CT=11  
CG=13 
overweight men 
49.0 ± 5.3 
16 wk.; 
3d/wk. 
3 sets; 
8 exercises; 
8-10 reps; 
8-10RM 
27.1 ± 4.0 27.3 ± 3.7 1.7 ± 1.3 2.7 ± 1.9 
Swift et al.(42) 
(2011) 
204 
CG=37 
AT=50 
RT=58 
CT=59 
obese men and 
women 
57.3 ± 8.1 
36 wk.; 
3d/wk. 
 
2-3sets; 
9 exercises; 
10-12 reps; 
34.1 ± 5.4 n/a 4.1 ± 4.5 -0.03  (1.08-1.02)c 
Abbreviations: kg=kilograms; m=meters; s.=seconds; hr.=hours; d=day; wk.=week; mo.=month; CRP= C - 
reactive protein; CG=control group; RT=resistance training; AT=aerobic training; ES=electrical 
stimulation; MVC=maximal voluntary contraction; RM= repetition maximum; BMI=body mass index; yr= 
years; T2D=Type 2 Diabetes; MS=Multiple Sclerosis; AA=African American; WA=White American; 
HiMF=high number of metabolic risk factors (2.9 ± 0.8); LoMF=low number of metabolic risk factors (0.5 
± 0.5); MIS=Maximum Isometric Strength; CI=confidence interval; SCHF=Stable Chronic Heart Failure 
unless otherwise noted, values expressed as mean ± SD or mean (SE) 
a mean (range) 
b mean change ± SD 
c mean change (95% CI) 
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Gender Differences in CRP and PA 
Several studies have revealed differences in CRP levels when comparing males and 
females or simply chose sex-specific CRP cut-points because women inherently have 
increased CRP in comparison to men. For example, in a 2002 study using data from the 
Third NHANES (1988-1994) the association between PA and CRP was investigated by 
Ford (43) using a sample that included 13,748 male and female adults (≥20 yr) using sex-
specific CRP cut-points (≥85th percentile).  Following adjustment for age, sex, ethnicity, 
education, work status, smoking status, cotinine concentration, hypertension, BMI, waist-
to-hip (WTH) ratio, high-density lipoprotein cholesterol (HDL-C), and aspirin use, the 
odds ratio (OR) for elevated CRP concentration were 0.98 (95% CI 0.78-1.23), 0.85 
(95% CI 0.70-1.02), and 0.53 (95% CI 0.40-0.71) for participants who reported engaging 
in light, moderate, and vigorous PA respectively during the previous month when 
compared to a referent group reporting no LTPA.  
When stratified by gender, several other studies analyzing the distribution of 
elevated CRP levels (>3 mg/L) or the relationship between PA, CRP, and adiposity have 
produced mixed results (44-49). In a study by Lear et al. (50) the effects of ethnicity and 
gender have on the relationship between CRP, BMI, WC, and WTH was investigated in 
women (n=47) and men (n=44) of Chinese decent and women (n=52) and men (n=39) of 
European descent recruited from a local hospital staff. Results revealed significantly 
lower CRP in Chinese men and women when compared with Europeans; however, this 
difference was no longer present after correction for either BMI or WC. In female 
participants, BMI (r=0.55, P<0.01) and WC (r=0.59, P<0.01) were significantly 
correlated with CRP. Gender also significantly interacted with WC to predict CRP 
following adjustment for age, smoking status, alcohol, and BMI (P<0.05). Interestingly, 
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the interaction between gender and BMI as a predictor of CRP was not significant in this 
population. Moreover, these investigators reported that once WC exceeded 70 cm, CRP 
levels increased at a greater rate in women than in men. 
Studies that investigated the frequency of participation in PA have also produced 
mixed results when stratified by gender. In 2004, Albert et al. (45) reported that in male 
(n=1,732) and female (n=1,101) adult (60.8 ± 12yr for both men and women) enrollees in 
the Pravastatin Inflammation/CRP Evaluation (PRINCE) study, concentrations of CRP 
were significantly lower among men who reported a high level of strenuous aerobic PA 
(≥4 times/wk) when compared with men who reported rarely performing strenuous 
aerobic PA (rarely/<once/wk). Furthermore, this association revealed in men remained 
significant following adjustment for age, HDL-C, smoking status, BMI, diabetes, aspirin 
use, and systolic blood pressure (SBP) (P for trend<0.001). However, a significant 
relationship was not found in women (P for trend=0.38).  
Interestingly, data collected from adult (65.3 ± 9.0 yr) male (n=1,926) and female 
(n=2,260) participants in the English Longitudinal Study of Ageing (ELSA) have also 
demonstrated independent associations between CRP and muscle strength that appear to 
be stronger in women (51).  In these participants, strength was assessed using hand grip 
strength and lower body strength (time required to complete five chair stands). Results 
revealed that about 33% of the study participants had an elevated CRP level (≥3 mg/L). 
Following adjustment for age, smoking, PA, education, and inflammatory diseases, 
elevated CRP levels were associated with poorer hand grip strength and lower body 
strength in women but only with lower body strength in men.  
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In a more recent 2011 study using data collected in older (>60 yr)  male (n=422) 
and female (n=445) adult participants in the NHANES 2001-2002, Canon et al. (46) 
reported that elevated levels of CRP may mediate the relationship between cognitive 
function and muscle quality in females but not males. The stated purpose of this study 
was to examine the sex-specific differences in the relationship between low muscle 
quality, impaired cognitive functioning, and the possible role of inflammatory markers. 
Muscle quality was calculated as isokinetic strength per unit muscle mass and skeletal 
muscle mass of the legs was measured using DXA. Interestingly, CRP was found to have 
a significant negative association with cognitive functioning for females but not males. 
These researchers concluded that the associations between sarcopenia and lower 
cognitive functioning may be partly due to systemic inflammation.  
In a study seeking to determine the race and gender differences in the distribution 
of CRP levels, Khera et al. (48) measured the CRP levels in 2,749 white and African 
American middle-aged (30-65 yr) enrollees in the Dallas Heart Study. Results of this 
study revealed significantly higher CRP levels in African American subjects when 
compared to white subjects (median, 3.0 vs. 2.3 mg/L; P<0.001). Analysis also revealed 
higher CRP levels in women when compared to men (median, 3.3 vs. 1.8 mg/L; 
P<0.001). The percentage of subjects in this population that would be considered high 
risk according to CRP level (>3 mg/L) was 31%, 40%, 51%, and 58% in white men, 
black men, white women, and black women, respectively. Following adjustment for CV 
risk factors, hormone replacement therapy, statin use, and BMI, when compared to a 
referent group of white men, an elevated CRP level (>3 mg/L) was more common in 
white women (OR 1.6; 95% CI 1.1-2.5) and black women (OR 1.7; 95% CI 1.2-2.6) but 
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not in black men. Thus, significant race and gender differences exist in this population 
when examining the distribution of CRP.  
Other investigators have also suggested that the increases in inflammatory 
biomarkers associated with obesity might be modified by gender. Thorand et al. (52) 
sought to investigate these relationships in men (n=641) and women (n=597) aged 55-74 
years who participated in the Kooperative Gesundheitsforschung in der Region Augsburg 
(KORA) survey 2000. This study was conducted in the area of Augsburg, Germany. In 
this population, all measures of adiposity (fat mass percentage, BMI, WC, WTH) were 
reported to be highly correlated with CRP in both male and female study participants. 
However, analysis revealed a higher percentage of variability in CRP concentrations was 
explained by body composition in women when compared to men. Furthermore, the 
relevance of individual measures varied by sex. For example, fat mass percentage 
explained the highest percentage of variability of CRP in women, 18.2%, and WTH 
explained the highest percentage of the variability of CRP in men, 6.2%. Interestingly, 
WC explained the highest percentage of variability in IL-6, a known upstream 
determinant of increased hepatic production of CRP, in women, 3.7%, and men, 1.8%, 
(P<0.001 for both). Thus, while adiposity was strongly associated with CRP levels in 
men and women, the association was reported to be considerably stronger in women.  
Gender differences have also been reported when investigating the relationships 
among adiposity, inflammation, PA, fitness, and fatigue (53). In 127 overweight 
(BMI=28.0 kg/m2) community-dwelling older (70 yr) adults, a significant (P<0.05) 
relationship between CRP (r=0.29) and fatigue has been reported by Valentine et al. (53) 
in women, but not men. In contrast, CRP levels of female study participants were 40% 
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higher and adiposity 12% higher in those reporting fatigue when compared to those 
reporting no fatigue. A similar relationship was not revealed in male study participants.  
When investigating the relationship between fitness and CRP, some evidence has 
also suggested the existence of gender differences in children and young adult 
populations. In a study published in 2003, Isasi et al. (44) investigated the association 
between treadmill assessed fitness levels and CRP in children and young adult males 
(n=95) and females (n=110) aged six to 24 years who participated in the Columbia 
University Biomarkers Study (1994-1998). Following adjustment for age, ethnicity, BMI, 
and family history of ischemic heart disease, fitness remained inversely associated with 
CRP levels only in males (β=-0.02; SE= 0.01, P=0.03).  
 
Summary 
Evidence suggests that PA may reduce inflammation, which is a critical process in the 
pathogenesis of cardiovascular disease. However, the association between MSA and CRP 
is less clear. Since CRP has shown efficacy in predicting incidence of CVD (4), 
examining the possible mediating associations between MSA and CRP may be 
particularly important for men and women who do not currently perform any volume of 
MSA, or for those performing volumes of MSA that do not meet the DHHS 
recommendation (MSA ≥2 d/wk). 
The reviewed studies included a variety of populations. Characteristics of study 
participants varied according to gender, age range, BMI class, and the presence of known 
inflammatory conditions. Consequently, it is very difficult to generalize the results from 
these studies to the broader population. Thus, it is important to examine the associations 
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between CRP and MSA using population-based or nationally representative data. The 
present study may also add to the current literature by demonstrating a more pronounced 
association among females and ethnic subgroups (47,48), as well as those reporting 
adiposity as a strong mediating factor (16,49,52). Moreover, since MSA participation is 
estimated to be lower in female subgroups (54,55), revealing a mediating association may 
become increasingly important for allied health care professionals who are able to 
promote MSA participation within these groups.  
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 The purpose of this study was to examine the associations between self-reported 
volumes of muscle strengthening activities (MSA) and elevated C – reactive protein 
(CRP) in adult participants of the National Health and Nutrition Examination Survey 
(NHANES) when stratified by gender. Emphasis in this study was placed on determining 
whether volumes of MSA meeting the 2008 Department of Health and Human Services 
(DHHS) recommendation (1) was associated with significantly lower odds of elevated 
CRP and the potential mediating effects of waist circumference on this association. This 
section provides the details of the methodology that was utilized to answer the research 
questions in this study.  
 
Data Collection 
This study utilized six years of data from the 1999-2004 NHANES. The NHANES is a 
continuous survey conducted by the National Center for Health Statistics (2). The 
NHANES was designed to provide national estimates of the health and nutritional status 
of non-institutionalized United States (U.S.) civilians over the age of two months. The 
NHANES also over-samples persons 60 and older, African Americans, and Hispanics to 
produce more reliable statistics. The participant interviews take place in the home of the 
survey participant. Participants who provided anthropometric measurements and 
biomarkers attended an examination session in one of the pre-equipped mobile 
examination centers (MEC). The study teams that operate these MEC units and collect 
these various measurements include a physician, medical technicians, and interviewers. 
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Sampling Design 
The NHANES data were obtained using a complex, multistage probability sampling 
design. The sample selection for the NHANES follows four stages.  First is the selection 
of primary sampling units (PSUs). These PSUs are usually counties or small groups of 
adjacent counties. Second is the selection of segments within these PSUs. These are made 
up of the equivalent of a city block or a group of blocks that contain a group of 
households. Third, households within these segments are randomly selected. Lastly, 
individuals within these households are selected at random to participate in the household 
interview section of the NHANES and possibly attend the MEC unit for the provision of 
other measurements and the serum necessary to examine biomarkers. 
 The design and weighting methods utilized in NHANES have been consistent 
over the history of the survey. The sampling weights are used to account for 1) the 
probability of selection; 2) the oversampling of African Americans, Mexican Americans, 
persons with low income, adolescents aged 12-19 years, persons aged ≥60 years; and 3) 
non-response rates. Thus, the weights utilized in the analyses in this study were used to 
account for the complex survey design, which including oversampling, survey 
nonresponse, and post-stratification to match the population control totals for each 
sampling subdomain. This last adjustment makes the weighted counts the same as an 
independent count of the U.S. 2000 Census. This step was important to ensure that the 
resultant estimates are representative of the U.S. population. A six year weight was 
created for the sub-sample of survey participants who attended the MEC. Creating the 
necessary six-year weight (WTSMEC6YR) was done while merging the six years of 
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survey data collected from 1999-2004 using SAS 9.2 (3). The SAS coding used to create 
the sample weight was as follows: 
if sddsrvyr in (1,2) then MEC6YR  = 2/3 *WTMEC4YR; ***1999-2002***; 
If sddsrvyr=3 then MEC6YR = 1/3 *WTMEC2YR; ***2003-2004***; 
Note, whenever utilizing the survey cycle variable (SDDSRVYR) 1=1999-2000, 2=2001-
2002, and 3=2003-2004. 
 
Subjects 
The total 1999-2004 NHANES sample size was 31,126, ages two months and above. For 
this study, the final sample consisted of 9,135 U.S. adults (≥20 years of age). The sample 
for this study met the following conditions: 1) adult men and women >20 years of age; 2) 
had provided a serum blood sample in a MEC; 3) if female, not pregnant; and 4) had 
provided complete data on all other variables of interest.   
 
Study Measures 
Dependent measure(s): C - reactive protein 
The dependent variable in this study was an elevated CRP concentration  
(3 mg/L<CRP≤10 mg/L) as defined by the Centers for Disease Control and Prevention 
and the American Heart Association (CDC/AHA) (4). C - reactive protein concentrations 
were measured using latex-enhanced nephelometry (N high-sensitivity CRP assay) on a 
Dade Behring II nephelometer at the University of Washington Medical Center. Seattle, 
Washington (5).  
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Primary Independent Measure(s): Muscle Strengthening Activity 
The primary independent variable in this study was calculated from ‘self-reported’ MSA 
patterns. The final sample provided responses to the following items from the physical 
activity questionnaire file item PAD440: Over the past 30 days, did {you/SP} do any 
physical activities specifically designed to strengthen {your/his/her} muscles such as 
lifting weights, push-ups or sit-ups? Include all such activities even if you have mentioned 
them before in the past 12 months. The sample also provided responses to physical 
activity questionnaire file item PAD460: Over the past 30 days, how often did you do 
these activities? [Activities designed to strengthen {your/his/her} muscles such as lifting 
weights, push-ups or sit-ups.] The MSA variable was created with three categories: no 
MSA, some MSA, and meeting the DHHS recommendations. No MSA was coded as 0 
d/wk, some MSA as ≥1 to <2 d/wk, and meeting the recommendation as ≥2 d/wk.  
 
Other Independent Measures 
The potential confounding variables that were controlled for in this study included the 
following: 
 
Age   
Age was divided into three categories: 20–39, 40–59, and ≥60 years. 
 
Race/Ethnicity   
Participants were classified as one of four race/ethnicity groups.  The four categories 
were:  non-Hispanic white, non-Hispanic black, Mexican American, and other.   
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Education 
Education was categorized into three levels: less than high school, high school graduate, 
and more than high school. 
 
Serum Cotinine 
Current evidence using data from the 1999-2004 NHANES has suggested that the use of 
the conventional cut-point of 14 ng/mL overestimates the number of nonsmokers in the 
U.S. adult population (6). Thus, the newly recommended lowered cut-point of 3 ng/mL 
was used to create a dichotomous variable of ≥3 ng/mL (yes/no) to distinguish smokers 
from nonsmokers. 
 
History of Cardiovascular Disease 
A dichotomous history of cardiovascular disease variable was created based on survey 
participant responses (yes/no) to a series of questions located within the medical 
conditions questionnaire (MCQ) portion of the NHANES.  These questions included the 
following: 
MCQ160B: “Has a doctor or health professional ever told {you/SP} that 
{you/s/he} ...had congestive heart failure?” 
MCQ160C: “Has a doctor or health professional ever told {you/SP} that 
{you/s/he} ...had coronary heart disease?” 
MCQ160D: “Has a doctor or health professional ever told {you/SP} that 
{you/s/he} ...had angina, also called angina pectoris?” 
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MCQ160E: “Has a doctor or health professional ever told {you/SP} that 
{you/s/he} ...had a heart attack (also called myocardial infarction)?” 
MCQ160F: “Has a doctor or health professional ever told {you/SP} that 
{you/s/he} ...had a stroke?” 
 
Hypertension 
A dichotomous hypertension variable was created based on the National Cholesterol 
Education Panel Adult Treatment Panel III (NCEP ATP III) criteria (7): systolic blood 
pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg (yes/no) or current use 
of blood pressure lowering medications. 
 
High-density Lipoprotein Cholesterol  
A dichotomous high-density lipoprotein cholesterol (HDL-C) variable was created based 
on the NCEP ATP III criteria (7): <40 mg/dL in men (yes/no) or <50 mg/dL in women 
(yes/no). 
 
Non-High-density Lipoprotein Cholesterol 
The use of non-HDL-C as a covariate was considered advantageous since it only requires 
the measurement of total cholesterol (TC) and HDL-C. The formula is as follows: Non-
HDL-C=TC-HDL-C. These variables do not require a fasting sample. In contrast, the 
measurement of LDL-C was only available in the fasting subsample (8). Non-HDL-C 
categories were created based on NCEP ATP III defined goals (7). These four non-HDL-
C (mg/dL) categories included levels <130, 130-159, 160-189, and >189 mg/dL. 
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Arthritis 
Arthritis status was dichotomized (yes/no) based on participants’ survey response to the 
following question located within the MCQ file: 
MCQ160A: “Has a doctor or other health professional ever told you that 
{you/SP} that {you/s/he} had arthritis?” 
 
Aspirin  
The use of aspirin has been previously described as a potential agent for lowering CRP 
levels (9). For this analysis, reporting the use of aspirin was dichotomized (yes/no) based 
on participant responses to the following question located in the analgesic medications 
(pain relievers) questionnaire file: 
RXQ300: “{Have you/ has SP} ever taken any of these prescription or over-the 
counter pain relievers nearly every day for the last month?” 
RXQ310: Code 10 - Aspirin - also buffered aspirin products such as Anacin, 
Bayer, Bufferin, Midol, Ascripton, Ecotrin, Pabrin and Alka Seltzer 
 
Glycohemoglobin 
Three glycohemoglobin (HbA1c %) diabetes status categories were created based on the 
American Diabetes Association definition (10). These categories included normal 
(<5.7%), pre-diabetes (5.7% to 6.4%), and those with diabetes (≥6.5%).  
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Hormone Replacement Therapy 
In gender stratified analyses, use of a dichotomous (yes/no) female hormone therapy 
variable was used as an additional covariate in analyses utilizing female participants. This 
variable was based on responses to the following item from the reproductive health 
questionnaire file: RHQ540: “{Have you/Has SP} ever used female hormones such as 
estrogen and progesterone? Please include any forms of female hormones, such as pills, 
cream, patch,  and injectables, but do not include birth control methods or use for 
fertility.” 
 
Waist Circumference 
Waist circumference (WC) was examined continuously in an effort to account for all 
waist circumference measurements and thus varying degrees of central adiposity. Waist 
circumference was measured using steel tape just above the uppermost lateral border of 
the right ilium to the nearest millimeter. 
 
Data Analysis 
The data in this study were initially managed using SAS 9.2 (3). SAS was used to 
conduct both complex variable recodes and data coding validation. SAS-callable 
SUDAAN (11) was then used to conduct the analysis, incorporating sampling weights 
within the context of the correlated multi-stage complex sampling design inherent to 
NHANES. Participants who responded ‘don’t know/not sure’, refused to answer, or had 
missing responses for any of the questions or measures were excluded from the analyses. 
Logistic regression models were stratified by gender and adjusted for age, race, 
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education, serum cotinine, HDL-C, non-HDL-C, arthritis, aspirin use, hypertension, 
history of CVD, HbA1c %, hormone therapy in females, and WC. Best fit models were 
created using a forward selection method based on the presence or absence of significant 
Wald f-test results. The resultant odds ratios were used to examine the associations 
between CRP and each of the remaining independent variables. 
 
Limitations 
The present study has several inherent limitations due to the design. Consequently, all 
findings must be interpreted with caution. These limitations include the use of the 
NHANES MSA data in these analyses which were collected from 1999-2004. Thus, the 
analyzed data may not be reflective of the current U.S. adult population. Furthermore, the 
MSA data was self-reported over the past 30 days and not objectively measured. As a 
result, the frequency, intensity, duration, and type of MSA is subject to recall bias and 
possible social desirability effect. Lastly, due to the nature of the cross-sectional study 
design, causality will not be able to be established. 
 
Summary 
The three research questions in this study were: 1) “Is there an association between 
volumes of MSA meeting the current DHHS recommendation and having an elevated 
CRP level?”, 2) “If a relationship does exist, is that relationship different for each 
gender?”, and 3) “Does waist circumference mediate this relationship.”  
 This is the first study to examine the potential gender differences in elevated CRP 
levels and volumes of MSA in adults aged ≥20 years in a nationally representative 
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sample of U.S. adults. This study adds to the evidence demonstrating gender specific 
differences between volumes of MSA and markers of inflammation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
References 
1. Physical activity guidelines for Americans; Be active, healthy, and happy. United 
States Department of Health and Human Services 2008. 
2. National Center for Health Statistics Centers for Disease Control and Prevention. 
NHANES Analytic and Reporting Guidelines. September 2006 version. 
3. SAS. Base SAS 9.2 Procedures Guide. Carey, NC: 2009. 
4. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and 
cardiovascular disease: application to clinical and public health practice: A 
statement for healthcare professionals from the Centers for Disease Control and 
Prevention and the American Heart Association. Circulation 2003;107:499-511. 
5. Laboratory Procedure Manual: C-Reactive Protein in Serum NHANES 2003–
2004.  
6. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum 
cotinine levels for distinguishing cigarette smokers and nonsmokers within 
different racial/ethnic groups in the United States between 1999 and 2004. Am J 
Epidemiol 2009;169:236-48. 
7. Executive Summary of The Third Report of The National Cholesterol Education 
Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High 
Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-
97. 
8. Hirsch GA, Vaid N, Blumenthal RS. The Significance of Measuring Non-HDL-
Cholesterol. Preventive cardiology 2002;5:156-159. 
55 
 
9. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 
2006;24:33-50. 
10. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes 
care 33:S62-S69. 
11. Research Triangle Institute. SUDAAN User's Manual, Release 8.0. Research 
Triangle Park, NC: 2001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
56 
 
 
 
 
 
 
Chapter Four: Gender Differences in High Sensitivity C - reactive Protein and Self-
Reported Muscle Strengthening Activity among U.S. Adults 
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Objectives We sought to examine the gender differences between C - reactive protein  
  (CRP) and muscle strengthening activity (MSA) in U.S. adults (≥20 years  
  of age). 
Background Elevated levels of CRP have been shown to be associated with an increase 
  in risk of cardiovascular disease (CVD). Studies analyzing the relationship 
  between physical activity (PA) and CRP by gender have produced mixed  
  results. 
Methods The sample (n=9,135) included participants in the 1999-2004 National  
  Health and Nutrition Examination Survey (NHANES). Three categories of 
  reported MSA participation were created: no MSA (referent group), some  
  MSA (≥1 to <2 d/wk), and meeting the 2008 Department of Health  
  and Human Services (DHHS) recommendation (>2 d/wk). The   
  dependent variable was elevated CRP (>3 to 10 mg/L).  
Results Gender stratified analysis revealed significantly lower odds of having  
  elevated CRP for women reporting some MSA (OR 0.61; 95% CI 0.45- 
  0.83, P=0.0023), or volumes of MSA meeting the DHHS recommendation 
  (OR 0.66; 95% CI 0.54-0.82, P=0.0004). Significantly lower odds of men  
  having elevated CRP was observed in those reporting MSA volumes  
  meeting the recommendation (OR 0.73; 95% CI 0.61-0.88, P=0.0011).  
  Following adjustment for waist circumference (WC) these odds remained  
  significant in men but not women.  
Conclusions Women reporting any MSA were found to have lower odds of having  
  elevated CRP when compared to those reporting no MSA prior to   
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  adjustment for WC. Significantly lower odds in men were only observed  
  in those meeting the recommendation. These results suggest that WC may  
  mediate the associations between MSA and CRP and this relationship may 
  be stronger in women.  
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Elevated levels of C - reactive protein (CRP), a non-specific marker of 
inflammation, have been shown to be associated with an increase in risk of 
cardiovascular disease (CVD) (1). Moreover, previous cross-sectional analyses have 
revealed statistically significant positive associations between CRP concentrations and 
self-reported myocardial infarction (2) and stroke (3). It has also been shown that 
physical activity (PA) participation has a role in reducing incidence of CVD (4). 
Although PA may produce a short term rise in circulating levels of CRP, long term 
participation in exercise training has been shown to reduce CRP levels (5). Some studies 
have suggested that the associations between PA and CVD may be mediated by 
inflammation (6,7).  
The Department of Health and Human Services (DHHS) 2008 Physical Activity 
Guidelines for Americans recommend that adults should do muscle-strengthening 
activities (MSA) that are moderate or high intensity and involve all major muscle groups 
on two or more d/wk because MSA provides additional benefits not found with aerobic 
activity (8). The benefits of MSA include increased bone strength, muscular fitness, and 
help maintaining muscle mass during a program designed to promote weight loss (8). 
Studies have also shown that protocols utilizing MSA are effective in decreasing 
circulating levels of CRP (9-11). However, there are few gender-stratified studies 
analyzing the distribution of elevated CRP (>3 mg/L) or the relationship between PA and 
CRP, and the limited current literature has revealed mixed results (12-17). The purpose of 
this study is to examine the associations between self-reported MSA and CRP in adult 
participants of the National Health and Nutrition Examination Survey (NHANES) when 
stratified by gender.  
60 
 
Methods 
This study utilized six years of data from the 1999-2004 NHANES, a continuous survey 
conducted by the National Center for Health Statistics (18). The NHANES is designed to 
provide national estimates of the health and nutritional status of non-institutionalized 
United States (U.S.) civilians over the age of two months. The overall response rates 
ranged from 76% to 80% for participants selected for examination in the 1999-2004 
NHANES. The total 1999-2004 NHANES sample size was 31,126, ages two months and 
above. A total of 15,332 adults (≥20 years of age) provided responses to the interview 
portion of 1999-2004 NHANES. Following the exclusion of 833 pregnant women and 16 
adults with missing responses related to MSA participation a total of 14,483 participants 
were available for further analysis. Of these participants, 12,643 adults (87%) attended a 
mobile examination center and provided the serum necessary for the measurement of 
CRP. Following the exclusion of adults with any missing values for other study 
covariates, the final sample consisted of 4,079 male and 5,056 female U.S. adults.  
 The primary independent variable in this study was frequency of participation in 
MSA activities and was calculated from ‘self-reported’ MSA patterns. The final sample 
provided responses to the following items which came from the physical activity 
questionnaire file item PAD440: Over the past 30 days, did {you/SP} do any physical 
activities specifically designed to strengthen {your/his/her} muscles such as lifting 
weights, push-ups or sit-ups? Include all such activities even if you have mentioned them 
before in the past 12 months. The sample also provided responses to PA questionnaire 
file item PAD460: Over the past 30 days, how often did you do these activities? 
[Activities designed to strengthen {your/his/her} muscles such as lifting weights, push-
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ups or sit-ups.] The MSA variable was created with three categories: no MSA, some 
MSA, and meeting the DHHS recommendations. No MSA was coded as 0 d/wk, some 
MSA as ≥1 to <2 d/wk, and meeting the recommendation as ≥2 d/wk.  
 Four categories of race were created: non-Hispanic white, non-Hispanic black, 
Mexican American, and other. Serum cotinine, a metabolite of nicotine that is used as a 
marker for active smoking and environmental tobacco smoke exposure, was 
dichotomized (yes/no) based on having a serum level ≥3 ng/mL (19). Non-high density 
lipoprotein cholesterol (non-HDL-C) was calculated by subtracting HDL-C from total 
cholesterol and divided into four categories: <130, 130 to <160, 160 to <190, and ≥190 
mg/dL based on goals recommended in the Third Report of the National Education 
Program Adult Treatment Panel III (NCEP ATP III) (20). Reduced HDL-C, based on the 
NCEP ATP III and American Heart Association/National Heart, Lung, and Blood 
Institute (AHA/NHLBI) definitions, was dichotomized  (yes/no) for men (<40 mg/dL or 
drug treatment) and women (<50 mg/dL or drug treatment) (20,21). Glycohemoglobin 
(HbA1c %) was divided into three categories based on American Diabetes Association 
(ADA) recommendations for diagnosis of diabetes mellitus: <5.7%, 5.7 to 6.4%, and 
>6.4% (22). Hypertension (systolic blood pressure ≥140 mmHg or diastolic blood 
pressure ≥90 mmHg or current antihypertensive drug treatment) was dichotomized 
(yes/no) using the NCEP ATP III definition (20). A dichotomous hormone therapy 
variable (yes/no) was created for women based on responses to the following item from 
the reproductive health questionnaire file item RHQ540: {Have you/Has SP} ever used 
female hormones such as estrogen and progesterone? Please include any forms of female 
hormones, such as pills, cream, patch, and injectables, but do not include birth control 
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methods or use for fertility. Lastly, waist circumference (WC), which was measured 
using steel tape just above the uppermost lateral border of the right ilium to the nearest 
millimeter, was examined continuously in order to examine the odds of having an 
elevated CRP concentration for every centimeter increment of WC.  
 The dependent variable in this study was elevated CRP (>3 to10 mg/L) (23). 
Tests with a CRP level of >10 mg/L are often due to acute conditions, and 
recommendations are to exclude such tests (23). C - reactive protein concentrations were 
measured using latex-enhanced nephelometry (Dade Behring Nephelometer II Analyzer 
System) at the University of Washington Medical Center. Seattle, Washington.  
The data in this study were initially managed using SAS 9.2 (24). SAS was used 
to conduct both complex variable recodes and data coding validation. SAS-callable 
SUDAAN (25) was then used to conduct the analysis, incorporating sampling weights 
within the context of the complex multistage sampling design inherent to NHANES. 
Following a forward selection process based on Wald F-test results, gender-specific best 
fit models were constructed. The resultant logistic regression models for men included 
the following covariates: HDL-C, non-HDL-C, HbA1c %, hypertension, serum cotinine, 
and WC. Best fit logistic regression models for women included the following covariates: 
race, non-HDL-C, hormone therapy, and WC. Possible effect modification by gender or 
MSA participation was tested by adding an interaction term to the logistic regression 
models. 
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Results 
Table 1 illustrates the prevalence estimates for elevated CRP in U.S. adults according to 
sample characteristics.  
 
Table 1. Prevalence of Elevated CRP According to Sample Characteristics: NHANES 1999-2004 
Covariates 
Men Women 
N Weighted % (SE %) N Weighted % (SE %) 
Total 4072 24.4 (0.93) 3464 36.0 (0.91) 
MSA     
None 2977 26.7 (1.08) 2756 38.5 (1.14) 
Some Activity 248 20.4 (3.15) 172 25.5 (2.62) 
Meets Recommendation 847 19.8 (1.30) 536 30.3 (2.15) 
Age     
20-39 1265 18.9 (1.31) 1025 30.3 (1.60) 
40-59 1302 25.8 (1.43) 1070 38.4 (1.61) 
≥ 60 1505 31.4 (1.51) 1369 42.0 (1.83) 
Race     
non-Hispanic white 2140 23.8 (1.14) 1790 35.3 (1.15) 
non-Hispanic black 687 27.7 (1.69) 597 38.6 (2.31) 
Mexican American 962 23.8 (1.21) 801 44.3 (1.60) 
Other 283 26.1 (2.51) 276 34.6 (2.92) 
Education     
< High School 1372 29.1 (1.65) 1096 39.7 (2.28) 
High School Graduate 937 25.1 (1.55) 850 36.8 (1.78) 
> High School 1763 22.4 (1.17) 1518 35.0 (1.55) 
Cotinine (ng/mL)     
< 3 2798 22.6 (1.17) 2754 35.8 (1.03) 
≥ 3 1274 28.3 (1.49) 710 36.6 (1.83) 
Low HDL-C (mg/dL)     
No 2551 20.7 (1.04) 1965 31.6 (1.11) 
Yes 1521 30.6 (1.61) 1499 42.9 (1.46)        
Non-HDL-C (mg/dL)     
< 130 1370 20.2 (1.34) 1361 28.6 (1.36) 
130 to < 160 1113 22.6 (1.12) 926 37.4 (1.57) 
160 to < 190 886 27.3 (2.05) 670 41.4 (2.40) 
≥ 190 703 31.5 (2.33) 507 52.3 (2.87) 
Glycohemoglobin (%)     
< 5.7 2957 21.8 (0.88) 2585 33.5 (1.05) 
5.7 to < 6.5 707 38.0 (3.58) 590 57.9 (4.18) 
≥ 6.5 408 41.1 (5.38) 289 53.0 (7.40) 
Hypertension     
SBP < 140 and DBP < 90 2582 22.1 (1.22) 2120 33.3 (1.03) 
SBP ≥ 140, or DBP ≥ 90 1490 32.5 (1.99) 1344 43.1 (3.15) 
Augmented WC     
No 2437 17.1 (1.02) 1367 20.8 (1.22) 
Yes 1635 36.4 (1.95) 2097 50.4 (1.23) 
Hormone Therapy     
No   2473 33.8 (1.16) 
Yes   991 41.8 (3.82) 
Independent variables included muscle strengthening activity (MSA), age (years), race, education, serum 
cotinine, low high-density lipoprotein cholesterol (HDL-C) Men (<40 mg/dL) Women (<50 mg/dL), non-
high-density lipoprotein cholesterol (non-HDL-C), Glycohemoglobin (%), hypertension, augmented waist 
circumference (WC) Men (yes: ≥102 cm, no: <102 cm), Women (yes: ≥88 cm, no <88 cm), and hormone 
therapy. 
Abbreviations: Elevated CRP, elevated C - reactive protein (>3 mg/L to ≤10 mg/L); SE, standard error; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; ng/mL, nanogram per milliliter; mg/dL, 
milligram per deciliter  
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The age-adjusted prevalence of elevated CRP levels among U.S. adult men and 
women was 24.4% and 36.0%, respectively (Table 1). The prevalence of elevated CRP 
increased with age in both men and women and was higher among Mexican-Americans 
and non-Hispanic blacks. Prevalence of elevated CRP was also higher in those with 
serum cotinine concentrations >3 ng/mL. When examined by non-HDL-C concentration, 
the prevalence of elevated CRP was shown to increase with increasing non-HDL-C 
concentration. The adjusted prevalence of elevated CRP concentrations was also 
increased in those with glycohemoglobin range from 5.7 to <6.5%, or ≥6.5%. The 
prevalence of elevated CRP was also increased in men and women with an augmented 
WC, 36.4% and 50.4%, respectively.  
The interaction term for gender and MSA participation in the multiple logistic 
regression model was not significant (P=0.3063), thus the term was not included in the 
resultant models. Tables 2 and 3 illustrate the results of the logistic regression analyses 
examining the associations between elevated CRP concentrations and MSA.  
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Table 2. Odds Ratios for Muscle Strengthening Activity as a Predictor of Elevated CRP for Men in a 
Sample from the National Health and Nutrition Examination Survey Cycles 1999–2004 
 
Independent variable(s) included in Model 1: muscle strengthening activity; Model 2: muscle strengthening 
activity, non-high density lipoprotein cholesterol, high density lipoprotein cholesterol, Serum Cotinine, 
Glycohemoglobin, and hypertension; Model 3 included all variables from Model 2 and waist 
circumference. 
*Significant predictors (P<0.05). 
Abbreviations: OR, odds ratio; CI, confidence interval; MSA, muscle strengthening activity; HDL-C, high 
density lipoprotein cholesterol; WC, waist circumference; BP, blood pressure; SBP, systolic blood 
pressure; DBP; diastolic blood pressure; cm, centimeter; mg/dL, milligram per deciliter; ng/mL, nanogram 
per milliliter  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable Model 1 
OR (95% CI) 
Model 2 
OR (95% CI) 
Model 3 
OR (95% CI) 
MSA    
None 1.00 1.00 1.00 
Some Activity 0.65 (0.46-0.92)* 0.80 (0.55-1.17) 0.90 (0.61-1.34) 
Meets Recommendation 0.57 (0.49-0.67)* 0.73 (0.61-0.88)* 0.77 (0.63-0.95)* 
 Non-HDL-C (mg/dL)    
< 130  1.00 1.00 
130 to < 160  1.20 (0.96-1.50) 1.11 (0.88-1.41) 
160 to < 190  1.59 (1.19-2.12)* 1.43 (1.07-1.91)* 
≥ 190  1.78 (1.36-2.31)* 1.56 (1.19-2.04)* 
HDL-C (mg/dL)    
≥ 40  1.00 1.00 
< 40  1.50 (1.25-1.81)* 1.24 (1.02-1.51)* 
Cotinine (ng/mL)    
< 3  1.00 1.00 
≥ 3  1.31 (1.09-1.59)* 1.55 (1.25-1.94)* 
Glycohemoglobin (%)    
< 5.7  1.00 1.00 
5.7 to < 6.5  1.79 (1.48-2.16)* 1.43 (1.14-1.78)* 
≥ 6.5  1.84 (1.27-2.66)* 1.35 (0.94-1.93) 
Hypertension    
SBP ≤ 140 and DBP ≤ 90  1.00 1.00 
SBP > 140, or DBP > 90  1.67 (1.32-2.12)* 1.32 (1.02-1.71)* 
WC (cm)    
   1.04 (1.03-1.05)* 
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Table 3. Odds Ratios for Muscle Strengthening Activity as a Predictor of Elevated CRP for Women 
in a Sample from the National Health and Nutrition Examination Survey Cycles 1999–2004 
 
Independent variable(s) included in Model 1: muscle strengthening activity; Model 2: muscle strengthening 
activity, non-high density lipoprotein cholesterol, race, and hormone therapy; Model 3 included all 
variables from Model 2 and waist circumference. 
*Significant predictors (P<0.05). 
Abbreviations: OR, odds ratio; CI, confidence interval; MSA, muscle strengthening activity; HDL-C, high 
density lipoprotein cholesterol; WC, waist circumference; cm, centimeter; mg/dL, milligram per deciliter  
 
Crude analysis revealed significantly lower odds of having an elevated CRP level 
for male participants reporting some MSA (OR 0.65; CI 0.46-0.92, P=0.0162), or 
volumes meeting the DHHS recommendation (OR 0.57; 0.49-0.67, P<0.0001) when 
compared to a referent group reporting no MSA (Table 2). Crude analysis also revealed 
significantly lower odds of having an elevated CRP level for female participants 
reporting some MSA (OR 0.49; CI 0.36-0.67, P<0.0001), or volumes meeting the DHHS 
recommendation (OR 0.62; CI 0.51-0.75, P<0.0001) when compared to a referent group 
of females reporting no MSA (Table 3). Following adjustment for select demographic 
and metabolic risk factors, the odds of having an elevated CRP level were 27% and 34% 
lower (P<0.01) in male and female U.S. adults meeting the DHHS recommendation, 
Variable Model 1 
OR (95% CI) 
Model 2 
OR (95% CI) 
Model 3 
OR (95% CI) 
MSA    
None 1.00 1.00 1.00 
Some Activity 0.49 (0.36-0.67)* 0.61 (0.45-0.83)* 0.79 (0.56-1.12) 
Meets Recommendation 0.62 (0.51-0.75)* 0.66 (0.54-0.82)* 0.93 (0.73-1.17) 
 Non-HDL-C (mg/dL)    
< 130  1.00 1.00 
130 to < 160  1.48 (1.25-1.75)* 1.43 (1.18-1.73)* 
160 to < 190  1.77 (1.40-2.24)* 1.53 (1.19-1.96)* 
≥ 190  2.69 (2.12-3.43)* 2.16 (1.70-2.73)* 
Race    
non-Hispanic white  1.00 1.00 
non-Hispanic black  1.23 (1.02-1.49)* 0.97 (0.80-1.17) 
Mexican American  1.55 (1.25-1.92)* 1.50 (1.25-1.80)* 
Other  0.92 (0.72-1.17) 1.05 (0.78-1.40) 
Hormone Therapy    
No  1.00 1.00 
Yes  1.60 (1.35-1.90)* 1.51 (1.26-1.81)* 
WC (cm)    
   1.05 (1.04-1.06)* 
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respectively (Tables 2 & 3, Model 2). Following adjustment for WC these odds were no 
longer statistically significant in women (Table 3, Model 3). In contrast, the attenuated 
odds of elevated CRP remained statistically significant in those reporting volumes of 
MSA meeting the DHHS recommendation (OR 0.77; CI 0.63-0.95, P=0.0148) (Table 2, 
Model 3). 
Compared to their respective referent groups with non-HDL-C levels <130 
mg/dL, men and women with non-HDL-C levels 160 to <190 mg/dL, or ≥190 mg/dL, 
were significantly more likely (P<0.05, all models) to have an elevated CRP level. 
However, the increased odds of having an elevated CRP level in men with non-HDL-C 
concentrations 130 to <160 mg/dL were not statistically significant. Men with low HDL-
C concentrations (<40 mg/dL) or elevated serum cotinine concentrations (≥3 ng/mL) 
were significantly more likely to have an elevated CRP level (P<0.05, all models). 
Having an HbA1c concentration of 5.7 to 6.4% or hypertension was also associated with 
a statistically significant increase in odds of having an elevated CRP level in male 
participants (P<0.05, all models).  
Our study findings revealed mixed results when examining the relationships 
between race and CRP in women. In comparison to a referent group of non-Hispanic 
white women, the odds of having an elevated CRP level for Mexican American women 
was significantly higher (P<0.001, all models). In comparison to female participants that 
did not report using hormone therapies, the odds of having an elevated CRP were 
significantly higher (P<0.0001, all models) for women using hormone therapies. Lastly, 
when examining WC measures in men and women the odds of having an elevated CRP 
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level were significantly higher for every centimeter increment in WC [men (OR 1.04; 
95% CI 1.03-1.05, P<0.0001), women (OR 1.05; 95% CI 1.04-1.06, P<0.0001)]. 
 
Discussion 
Although some studies have shown that participation in various forms of MSA is 
associated with a decrease in concentrations of CRP, the study populations were 
generally small and not representative of the U.S. population (9-11). For example, in a 
sample of 44 young male African American and white volunteers, six weeks of resistance 
training resulted in a significant decrease in CRP in African American subjects (Mean ± 
SE; Baseline CRP 4.84 ± 0.9 vs. Post Training CRP 2.34 ± 0.5 mg/L, P<0.05) (9). 
Volunteers trained three d/wk for approximately 60 minutes per session. Three sets of 
five different exercises per session were performed with a one to two minute rest period 
between each set.  Load was progressively increased to ensure fatigue within 
approximately eight to12 repetitions. The study protocol utilized a split routine designed 
to alternate exercises for legs, back, and biceps on one day and exercises for the chest, 
shoulders, and triceps on a separate day. Thus, the selected exercises would effectively 
stress the major muscle groups of the upper and lower body. Interestingly, the observed 
decrease in CRP in these male African American volunteers remained statistically 
significant following a four week detraining period (CRP 1.91 ± 0.4 mg/L).  
 Stewart et al. (10) examined the influence of a 12 week exercise protocol that 
utilized a combination of aerobic and resistance training on CRP concentrations in 29 
younger (18-35yr) and 31 older (65-85yr) subjects. Participants trained three days per 
week and each session included a warm-up, 20 minutes of aerobic training 
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(walking/jogging) on a treadmill (70-80% of heart rate reserve), and two sets of eight 
resistance exercises [70-80% one repetition maximum (1RM),  second set performed to 
momentary failure] followed by a stretching and cool down period.  Intensity was 
adjusted bi-weekly. These investigators reported a 58% decrease (P<0.01) in serum CRP 
concentrations from pre- to post-training in those classified as inactive prior to study 
participation.  
 Donges et al. (11) investigated the effects of 10 weeks of exercise training on 
interleukin-6 and CRP in a sample of 102 male (n=45) and female (n=57) sedentary 
subjects. Subjects were assigned to a resistance group (n=35), an aerobic group (n=41), 
or a control group (n=26) that remained sedentary. Training sessions began with five 
minutes of dynamic stretching and concluded with five minutes of stretching. The 
resistance training protocol utilized pulley-weight machines and exercises were 
performed at 10 repetition maximum (~75% of a 1RM). Resistance exercises included 
chest press, shoulder press, lat pull-down, seated row, leg press, leg curl, and lunge. 
Participants performed two to three sets of eight to10 repetitions with a two-minute rest 
period between sets. Intensity was adjusted accordingly to promote training to 
‘‘momentary muscle failure.’’ Aerobic training (~75% of maximum heart rate) was 
conducted using Monark stationary cycle ergometers. Interestingly, only resistance 
training resulted in a significant attenuation of CRP concentration, 32.8% (P<0.05).  
Our findings support previous studies reporting adiposity as a mediating factor in 
the association between MSA and CRP levels in men and women (26-31). In an analysis 
using baseline data from the Health, Aging and Body Composition Study, Colbert et al. 
(27) reported that CRP levels were significantly lower in older (70-79 yr) black and white 
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adult study participants reporting higher levels of exercise (≥180 min/wk) that included 
resistance training (e.g., weight training, calisthenics). However, the relationship between 
exercisers and non-exercisers was not statistically significant following adjustments for 
total body fat and visceral fat. Other studies have also noted the associations between 
body fat and elevated CRP concentrations (28), an association which has also been 
consistently shown to be stronger in women (26,29-31). 
When stratified by gender, previous studies analyzing the distribution of elevated 
CRP (>3 mg/L), or the relationship between PA and CRP, have produced mixed results 
(12-17). In a study of older adults conducted by Canon et al. (14), elevated levels of CRP 
mediated the relationship between cognitive function and muscle quality in females but 
not males. Albert et al. (13) reported that concentrations of CRP in participants of the 
Pravastatin Inflammation/CRP Evaluation study were statistically significantly lower 
among middle-aged men who self-reported a high level (≥4 times/wk) of strenuous 
aerobic PA (e.g., swimming, running, aerobics, cycling). However, when compared with 
a referent group of reporting participating in strenuous aerobic PA less than once per 
week, this relationship was not statistically significant in women (mean age in years, 60.8 
± 12 for both men and women). A study examining the association between fitness and 
CRP levels in children and young adult participants (n=205) in the Columbia University 
BioMarkers Study aged six to 24 years revealed statistically significant inverse 
associations only in male participants (12). Previous studies have also demonstrated 
independent associations between CRP and hand grip and lower body strength that 
appear to be stronger in women (32,33).  
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In men, the 1999-2004 NHANES data showed a statistically significant inverse 
association between having an elevated CRP concentration and meeting the current 
DHHS recommendations. In women, a statistically significant inverse association was 
demonstrated in those reporting any level of MSA participation. These associations were 
independent of race, increased levels of non-HDL-C, and hormone therapies in women 
and reduced HDL-C levels, increased levels of non-HDL-C, increased HbA1c, 
hypertension, and increased serum cotinine concentrations in men. However, adjustment 
for WC attenuated the protective association between reporting MSA and having elevated 
CRP in men and resulted in an absence of statistically significant associations in women 
for any volume of MSA. Since CRP has shown efficacy in predicting risk of incident 
CVD (34), these findings may be particularly important for men and women who do not 
currently perform any volume of MSA, or for men performing volumes of MSA that do 
not meet the recommendation. 
The observed associations between CRP and MSA were also consistent with other 
studies which have demonstrated more pronounced associations among non-Caucasian 
female subgroups (15,16) and those reporting adiposity as a strong mediating factor 
(17,28,29). Consequently, because MSA participation has been estimated to be lower in 
female subgroups (35), it may become increasingly important for health care 
professionals to promote MSA participation in these groups. 
 Our study included some inherent strengths and limitations. The NHANES 
sample is large and representative of the U.S adult population. This strengthens the 
external validity of our study. However, since the data for these analyses were collected 
from 1999-2004 it may not be reflective of the current population. Other limitations 
72 
 
include the use of the MSA data, which were self-reported over the past 30 days and not 
objectively measured. Thus, the frequency, intensity, duration, and type of MSA are 
subject to recall bias. Lastly, due to the nature of the cross-sectional study design, 
causality cannot be inferred. 
 
Conclusions 
Our population-based findings add to the current evidence suggesting that MSA is 
associated with lower levels of CRP. Women reporting any MSA were found to have 
significantly lower odds of having elevated CRP when compared to those reporting no 
MSA. However, significantly lower odds in men were only observed in those meeting the 
DHHS recommendation. These results also suggest that adiposity may mediate the 
associations between MSA and CRP. Future studies should examine the associations 
among MSA, CRP, and other markers of metabolic health. 
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Associations between High Sensitivity C - reactive Protein and Self-Reported Screen 
Time in U.S. Adults 
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Objectives The purpose of this study was to examine the associations between  
  elevated CRP and screen time in a nationally representative sample of  
  U.S. adults. 
Background High sensitivity C - reactive protein (CRP) has shown efficacy in   
  predicting risk of adverse cardiovascular events and increased screen time  
  has been shown to be positively associated with cardiometabolic risk.  
Methods Study sample (n=7,645) included adults (≥20 years of age) who   
  participated in the 2003-2006 National Health and Nutrition Examination  
  Survey. Logistic regression was utilized to examine the association  
  between elevated CRP and screen time.  
Results Analysis revealed that individuals with CRP concentrations >3 to10 mg/L  
  had an increased odds of reporting ≥3 hours/day of screen time when  
  compared to those with CRP levels <3 mg/L (OR 1.27; 95% CI 1.15-1.41,  
  P<0.001). This association remained significant (OR 1.25; 95% CI 1.13- 
  1.39, P<0.001) following adjustment for physical activity and waist  
  circumference.  
Conclusions These data suggest that elevated levels of CRP were significantly   
  associated with reporting greater amounts of self-reported screen time  
  independent of meeting physical activity recommendations or waist  
  circumference. 
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 C - reactive protein (CRP) is an acute phase protein synthesized by hepatocytes 
and adipocytes in response to inflammation (1).  C - reactive protein has shown 
usefulness as a predictor of the future risk of adverse vascular events (2).  In 2003 a 
statement for healthcare professionals from the Centers for Disease Control and 
Prevention (CDC) and the American Heart Association (AHA) on the clinical application 
of markers of inflammation and cardiovascular disease (CVD) (3) was issued suggesting 
the use of CRP as a risk marker for CVD in those with Framingham risk scores projecting 
a 10 year coronary heart disease (CHD) risk between 10% and 20%.  The AHA and the 
CDC designate CRP levels by relative risk categories, with low, average, and high 
corresponding to approximate values of <1.0, 1.0-3.0, and >3.0 mg/L. 
 Findings from studies using data from the 1999-2000 National Health and 
Nutrition Examination Survey (NHANES) have been used to provide prevalence 
estimates of CRP values ≥ 3 mg/L in adult (≥20 yr) men (4) and women (5). The findings 
from these studies revealed that 22.1% of men (n=1,940) and 30.6% of women not 
currently taking hormone replacement (n=1,787) had elevated CRP concentrations 
(3<CRP≤10 mg/L). Furthermore, multivariable logistic regression analysis comparing 
these age-adjusted proportions has revealed significantly increased odds of having an 
elevated CRP concentration in women when compared with men (OR 2.59; 95% CI 
1.96–3.42, P<0.001).  
 According to the Nielsen Cross-Platform Report (6), Americans spent 
approximately 34 hours per week viewing television in the third quarter of 2012. It was 
also reported that Americans are spending close to five hours per week viewing a 
computer screen. Television was by far the most predominant form of screen time (ST) 
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being reported. Analysis of prospective studies suggest that longer durations of ST are 
consistently associated with a higher risk of diabetes, fatal or nonfatal CVD, and all-
cause mortality (7). In the United States (U.S.) population, it has been estimated that 25% 
of adults are sedentary and 60% are not regularly active (8).  An analysis by Katzmarzyk 
et al. (9) indicates that life expectancy may be extended by two years if time spent sitting 
was reduced to <3 h/day and 1.38 years if television viewing was reduced to <2 h/day.  
Studies investigating television viewing and leisure time sedentary behaviors have also 
found positive correlations among markers of CVD and sedentary behavior independent 
of physical activity (PA) participation (10-13). Sisson et al. (10) reported an 
approximated two-fold increase in odds of metabolic syndrome for men reporting ≥4 
h/day of ST independent of meeting current PA recommendations. 
 Accumulating evidence has shown that high sensitivity CRP decreases in a dose 
response manner with increased amounts of self-reported leisure time PA (14). 
Consequently, the inverse association is postulated to exist with the absence of PA. The 
purpose of this study was to examine the relationship between self-reported ST, using the 
2003-2006 NHANES questionnaire data collected on the hours spent viewing television 
and using a computer, and CRP in a population based sample of U.S. adults. Moreover, 
we will assess the associations with elevated CRP serving as the exposure variable and 
the likelihood of reporting increased amounts of screen time as the outcome. To the 
author’s knowledge, the multiple logistics regression model employed in this analysis has 
never been previously attempted. 
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Methods 
This cross-sectional study utilized four years of data from the 2003-2006 NHANES, a 
continuous survey conducted by the National Center for Health Statistics (15). The 
NHANES uses complex, multistage probability design to obtain a representative sample 
of the non-institutionalized U.S. population. The NHANES provides national estimates of 
the health and nutritional status of U.S. civilians over the age of two months. The total 
2003-2006 NHANES sample was 20,470. For this study, the final sample consisted of 
7,645 male and female adults (≥20yr). Participants in this study included those who met 
the following criteria; provided PA data during the household interview; provided non-
fasting serum samples necessary for the measurement of CRP in a mobile examination 
center; if female, not pregnant; and completed an informed consent. 
 The dependent variable in this study was calculated from ‘self-reported’ TV and 
computer use patterns by hours per day. The final sample provided responses to the 
following items which came from the Physical Activity Questionnaire (PAQ) file; 
PAD590: Over the past 30 days, on average about how many hours per day did {you/SP} 
sit and watch TV or videos? PAD600: Over the past 30 days, on average about how many 
hours per day did {you/SP} use a computer or play computer games? (16,17). A 
dichotomized hours of screen time per day variable was created (<3hours/day and 
≥3hours/day). 
 The independent variable of interest in this study was elevated CRP levels  
(>3 to 10 mg/L). This level corresponds to the CRP level classified as high risk according 
to the AHA and National Heart, Lung, and Blood Institute recommendations (3). As per 
the AHA recommendation, those with CRP levels >10 mg/L were excluded from analysis 
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since these levels are associated with the presence of acute inflammation. The AHA 
recommends that CRP levels >10 mg/L be discarded and repeated in two weeks to allow 
acute inflammations to subside before retesting. The created CRP variable was 
dichotomized (elevated CRP, yes/no). In the 2003-2006 NHANES CRP concentrations 
were measured using latex enhanced nephelometry on a Dade Behring Nephelometer II 
Analyzer System at the University of Washington Medical Center. Seattle, Washington 
(18,19).   
 Age was divided into three categories: 20-39, 40-59, and ≥60 years. Four 
categories of race were created: non-Hispanic white, non-Hispanic black, Mexican 
American, and other. Education was used as the measure of socioeconomic status. 
Education was divided into four categories: less than high school, high school graduate, 
some college, and college graduate. A three level smoking status variable was created: 
current smoker, former smoker, and non-smoker. Augmented waist circumference was 
dichotomized for men (≥102 cm, yes or no) and women (≥88 cm, yes or no) (20).  
 The PA variable used in examining the possible inverse associations between 
volumes of PA and ST was based on the 2007 American College of Sports 
Medicine/AHA PA recommendation (21). Volumes of PA (MET·min·wk-1) were divided 
into three categories: inactive, insufficiently active, and meets PA recommendations. 
Individuals reporting five d/wk of moderate intensity PA for 30 minutes, or three d/wk of 
vigorous intensity PA for 20 minutes, were classified as meeting the recommendation. 
Individuals reporting at least one time/wk at any duration or intensity were classified in 
the insufficient category. Individuals reporting no PA were classified as inactive. 
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 Data from the 2003-2006 NHANES were analyzed to determine the odds of U.S. 
adults with elevated CRP concentrations reporting increased amounts of ST. The data in 
this study were initially managed using SAS 9.2 (22).  SAS was used to conduct complex 
variable recodes and data coding validation. SAS-callable SUDAAN (23) was used to 
conduct the analysis, incorporating sampling weights within the context of the correlated 
multi-stage complex sampling design inherent to NHANES. PROC CROSSTAB was 
used for calculating descriptive statistics for the categorical variables. Multivariable 
logistic regression models, using PROC RLOGIST, were created to calculate the odds 
ratios and 95% confidence intervals for participants who reported increased amounts of 
ST having elevated CRP. The three logistic regression models that were created included 
the primary independent variable CRP controlling for age, a second model adding gender, 
race, education, smoking status, and waist circumference (WC), and a third model 
controlling for PA volume. Any participants who responded ‘don’t know/not sure’, 
refused to answer, or had missing responses for any of the questions or measures were 
excluded from analysis. Less than 10% of survey participants had missing television and 
computer screen time data. Of the participants that provided serum blood samples in the 
NHANES mobile examination centers, approximately 10% had missing data for CRP in 
the 2003-2004 and the 2005-2006 cycles of NHANES. 
 
Results 
Prevalence estimates revealed that 31.4 % of participants reporting three or more hours of 
ST had elevated CRP values. In contrast, 24.5% of participants reporting less than three 
hours had elevated CRP values (P<0.001). Table 1 shows the results of the logistic 
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regression analysis examining the association between elevated CRP and increased 
amounts of ST.  
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Table 1. Odds Ratios for reporting ≥3 hours per day of screen time among adult participants ≥20 
years of age: NHANES 2003-2006 
Independent variables included in Model 1: C - reactive protein (CRP) and age; Model 2: CRP, age, 
gender, education (<high school vs. college graduate, high school graduate vs. college graduate, and some 
college vs. college graduate), race ((non-Hispanic(nH) black vs. nH white, Hispanic vs. nH white, and other 
vs. nH white)), smoking (current vs. never and former vs. never), and augmented waist circumference(WC) 
(men ≥ 102 cm, women ≥ 88 cm); Model 3 included all variables from Model 2 and physical activity PA 
(insufficiently active vs. meeting PA recommendation and inactive vs. meeting PA recommendation).  
*Significant predictors (P<0.05)  
Abbreviations: OR, odds ratio; CI, confidence interval 
 
Variable Model 1 
OR (95% CI) 
Model 2 
OR (95% CI) 
Model 3 
OR (95% CI) 
CRP    
≤3 mg/L 1.00 1.00 1.00 
>3 mg/L, ≤10 mg/L 1.37(1.23-1.53)* 
 
1.27(1.15-1.41)* 1.25(1.13-1.39)* 
 Age    
20-39 1.00 1.00 1.00 
40-59 1.00(0.86-1.16) 0.95(0.81-1.10) 0.90 (0.78-1.05) 
≥60 2.07(1.80-2.38)* 1.89(1.60-2.24)* 1.79(1.53-2.11)* 
Gender    
Female  1.00 1.00 
Male  1.16(1.02-1.32)* 1.16(1.02-1.32)* 
Education    
College Graduate  1.00 1.00 
Some College  1.63(1.43-1.86)* 1.58(1.38-1.82)* 
High School   2.22(1.92-2.55)* 2.10(1.81-2.42)* 
<High School  2.19(1.81-2.66)* 2.00(1.63-2.44)* 
Race    
non-Hispanic white  1.00 1.00 
non-Hispanic black  1.97(1.63-2.39)* 1.97(1.63-2.39)* 
Mexican American  0.74(0.62-0.87)* 0.73(0.62-0.86)* 
Other  0.94(0.76-1.16) 0.93(0.75-1.16) 
Smoking Status    
Never Smoked  1.00 1.00 
Former Smoker  1.33(1.15-1.54)* 1.32(1.14-1.53)* 
Current Smoker  1.67(1.46-1.92)* 1.59(1.38-1.82)* 
Augmented WC    
No  1.00 1.00 
Yes  1.19(1.03-1.37)* 1.17(1.01-1.36)* 
Physical Activity    
Meets Recommendation   1.00 
Insufficiently Active   1.10(0.96-1.27) 
Inactive   1.26(1.07-1.47)* 
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Age-adjusted analysis revealed significantly increased odds of reporting three or 
more hours of ST for participants with elevated CRP when compared to a referent group 
with values ≤3 mg/L (OR 1.37; CI 1.23-1.53, P<0.001). The association between elevated 
CRP and increased ST remained significant following adjustments for demographic and 
lifestyle factors (OR 1.27; CI 1.15-1.41, P<0.001) and PA volume (OR 1.25; CI 1.13-
1.39, P<0.001). In comparison to a referent group with CRP values ≤3 mg/L, those with 
values >3 mg/L-10 mg/L, were 25% more likely (P<0.001) to report three or more hours 
of ST per day, independent of self-reported PA volumes and degree of central adiposity. 
Furthermore, U.S. adults reporting no PA were 26% more likely (P=0.006) to report three 
or more hours of ST per day. In comparison to a referent group aged 20-39 years, those 
≥60 years of age were approximately two times more likely (P<0.001) to report three or 
more hours of ST in all three models. In comparison to women, men were significantly 
(P=0.021) more likely to report three or more hours of ST per day. 
 Additionally, compared to college graduates and individuals reporting never 
smoking, education level (P<0.001, all levels) and current smoking status (P<0.001, all 
levels) reveal a similar increased odds for reporting three or more hours of ST per day. 
Our study findings revealed mixed results when examining race. In comparison to a 
referent group of non-Hispanic whites, the odds of reporting three or more hours per day 
of ST in non-Hispanic blacks was significantly higher (OR1.97; CI 1.63-2.39, P<0.001), 
while Mexican Americans were found to have significantly lower odds (OR 0.73; CI 
0.62-0.86, P<0.001). 
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Discussion 
In a nationally representative sample of U.S. adults we found that elevated CRP 
concentrations were positively associated with self-reporting three or more hours of ST 
per day. We also found a statistically significant trend (P=0.021) when adjusting for PA 
volume (Table 1). To our knowledge this is the first study to examine the associations 
among increased amounts self-reported ST with elevated CRP concentrations serving as 
the independent variable of interest.  
 These population based findings add to the current evidence regarding the 
harmful associations between increased sedentary behavior and CRP (1,12,13,24).  In a 
recent review of prospective studies examining the associations between self-reported ST 
and sitting time and CVD, Ford et al. (25) reported that greater sedentary time is 
associated with an increased risk of fatal and non-fatal CVD independent of volume of 
PA. Other prospective studies have also supported an independent relationship between 
sedentary time and type II diabetes, in addition to all-cause and CVD mortality (26). 
However, though many prospective and cross-sectional studies have demonstrated a 
deleterious association between increased sedentary behavior and CVD, adults continue 
to engage in increased amounts of ST, with television being the most commonly reported 
leisure time sedentary activity (6,27,28). 
 Our findings are consistent with those of Stamatakis et al. (12), who reported that 
in a sample (n=4,512) of adult (≥35yr) Scottish Health Survey respondents, CRP levels 
were approximately three fold higher in those spending >4 hours per day in ST. This 
explained much of the observed ST and CVD association.  The observed associations 
between CRP and ST were consistent across sex, age, and ethnic subgroups. 
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 The findings from sedentary time studies using objectively measured data also 
support our findings (13). Healy et al. (13) reported that independent of covariates 
including exercise time, there were statistically significant detrimental associations 
between sedentary time and CRP in a representative sample of 4,757 adult (≥20 yr) who 
participated in the 2003-06 NHANES. These investigators reported that sedentary time 
was detrimentally associated with CRP concentrations, while breaks in sedentary time 
were beneficially associated.  
 The findings of this study become increasingly important when considering the 
implications in the workplace. Sedentary jobs have been reported to have increased 83% 
since 1950, and Americans work approximately 47 hours a week, which is 164 more 
hours a year than 20 years ago (29). Since this trend toward increased ST is likely to 
coincide with technological advances, it will become increasing important to consider 
new ways to increase overall PA participation (30).  
 The strengths of our study include strong external validity due to the use of a 
large representative sample of U.S. adults, and the use of objective measures of 
inflammation and other CVD risk factors. Our study is not without limitations. First, the 
cross-sectional study design limits our ability to make causal inferences about the 
relationship between ST and CRP. Second, the sample analyzed is limited to the non-
institutionalized population.  Third, self-reported responses were subject to the social 
desirability effect. Since self-reported estimations are subject to bias, this may have 
resulted in an under or over estimation of the strength of the associations between the 
variables of interest. Lastly, though many covariates were considered, other unknown 
factors may have contributed to the observed associations. 
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Conclusions 
In this cross-sectional study, elevated levels of CRP were significantly associated with 
greater amounts of self-reported ST independent of PA or augmented central adiposity. 
Therefore, decreasing sedentary ST may become an important addition to future 
recommendations for regular PA. Communicating the importance of reducing ST and 
increasing PA is becoming an increasingly important goal for health care professionals. 
Future studies should continue to investigate CRP, objectively measured sedentary 
behaviors, and the clinical implications for identifying associated cardio-metabolic risk 
factors. 
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Appendix C 
 
Associations between Vigorous Intensity Physical Activity and C - reactive Protein 
in U.S. Adults: NHANES 1999-2006 
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Objectives We sought to examine the associations between high sensitivity C - 
  reactive protein (CRP) and vigorous intensity physical activity (VIPA) in a 
  nationally representative sample of U.S. adults.  
Background Though evidence has revealed inverse associations between physical  
  activity and CRP, the research on the associations between VIPA and  
  elevated CRP levels using nationally representative samples remains  
  sparse. 
Methods Sample (n=6,242) included adults (>20 years of age) that participated in  
  the 1999-2006 National Health and Nutrition Examination Survey.  
  Reported VIPA was categorized into none, insufficient (<500   
  MET∙min∙wk-1), and meeting the 2008 Department of Health and Human  
  Services PA recommendation (>500 MET∙min∙wk-1). The dependent  
  variable was elevated CRP (3<CRP<10 mg/L). Logistic regression  
  analysis was used to estimate odds and adjust for potential confounding  
  variables.  
Results Analysis revealed significantly lower odds of having elevated CRP for  
  those reporting insufficient volumes of VIPA (OR 0.70; 95% CI 0.58- 
  0.85, P=0.0004) or meeting the 2008 DHHS PA recommendation (OR  
  0.66; 95% CI 0.53-0.82, P=0.0003). This protective inverse association  
  was independent of several metabolic risk factors.  
Conclusions In a representative sample of U.S. adults, reporting any VIPA was   
  associated with significantly lower odds of having an elevated CRP level  
  when compared to those reporting no VIPA. These results suggest an 
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  inverse dose-response relationship may exist between VIPA and elevated  
  CRP levels. Future studies should examine the associations among  
  objectively measured VIPA, CRP, and other markers of metabolic health. 
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 C - reactive protein (CRP) is an acute phase marker of inflammation that has 
shown efficacy in predicting incident cardiovascular disease (CVD) (1). In a statement 
for healthcare professionals from the Center of Disease Control and Prevention (CDC), 
and the American Heart Association (AHA), decreased levels of CRP were associated 
with increased physical activity (PA) and endurance exercise (2). In this statement the 
recommended diagnostic cut-points for the high-sensitivity CRP assay were as follows; 
relative risk categories (low, average, high) correspond to approximate values  of <1.0, 
1.0 to 3.0, and >3.0 mg/L, respectively. It is also recommended that values exceeding 10 
mg/L be discarded and other causes of inflammation should be investigated.  
 The 2008 Department of Health and Human Services (DHHS) PA guidelines for 
Americans recommend 150 minutes of moderate intensity PA (MIPA) per week or 75 
minutes of vigorous intensity PA (VIPA) per week, or an aggregate of both, for overall 
health benefits and prevention of chronic diseases (3).  A recent review of several cross-
sectional studies revealed a consistent inverse association between PA and CRP (4). 
However, overall there is a paucity of research on the associations of VIPA with elevated 
CRP levels using nationally representative samples. The purpose of this study was to 
examine the associations between volumes of VIPA and elevated CRP in a nationally 
representative sample of U.S. adults 
 
Methods 
This cross-sectional study utilized eight years of data from the 1999-2006 NHANES, a 
continuous survey conducted by the National Center for Health Statistics (5). The 
NHANES uses complex, multistage probability design to obtain a representative sample 
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of the non-institutionalized U.S. population over the age of two months. The total 1999-
2006 NHANES sample N was 40,124. Participants in this study met the following 
inclusion criteria; were ≥20 years of age; provided the necessary VIPA data; provided a 
serum sample for the measurement of CRP in a mobile examination center; if female, not 
pregnant; and completed the required informed consent. The final sample that met the 
study inclusion and exclusion criteria consisted of 6,242 U.S. adults >20 years of age.  
 Four categories of race were used: non-Hispanic white, non-Hispanic black, 
Mexican American, and other. A three level smoking status variable was created: current 
smoker, former smoker, and non-smoker. A dichotomous diabetes status variable was 
created using fasting blood glucose levels (fasting glucose level ≥126 mg/dL, or <126 
mg/dL), diabetes medication use, and self-reported diabetes utilizing the following 
questions from the diabetes questionnaire files within NHANES, DIQ010 “{Other than 
during pregnancy, {have you/has SP}/{Have you/Has SP}} ever been told by a doctor or 
health professional that {you have/{he/she/SP} has} diabetes or sugar diabetes?” 
(yes/no) and DIQ070 “{Is SP/Are you} now taking diabetic pills to lower {{his/her}/your} 
blood sugar? These are sometimes called oral agents or oral hypoglycemic agents” 
(yes/no). A dichotomous low-density lipoprotein cholesterol (LDL-C) variable was 
created based on the current definition of high levels of LDL-C (<160 mg/dL vs. ≥160 
mg/dL) (6). Reduced high density lipoprotein cholesterol (HDL-C) was dichotomized for 
men (≥40 mg/dL or <40 mg/dL) and women (>50 mg/dL or <50 mg/dL) and augmented 
waist circumference (WC) was dichotomized for men (≥102 cm, yes/no) and women 
(≥88 cm, yes/no) based on National Heart, Lung, and Blood Institute/AHA guidelines (7). 
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 The independent variable of interest in this study was volume of self-reported 
VIPA. Data from the NHANES individual PA files (8) were accessed to estimate 
volumes of VIPA. These files include information on different types of PA. The 
compendium of PA (9) was used to assign metabolic equivalent (MET) levels to each 
activity. METs are obtained by dividing oxygen uptake in mL∙kg∙min-1 by 3.5 
mL∙kg∙min-1 (10). The average duration (minutes per session) was then multiplied by the 
average frequency (number of sessions per week) and intensity level (METs) to calculate 
the MET∙min∙wk-1 specific to each VIPA (>6METs). The continuous MET∙min∙wk-1 
variable was used to create a three level categorical VIPA variable. The first level 
represented those reporting no VIPA during the past month (referent). The remaining 
MET/min/wk-1 were categorized as those reporting <500 and >500 MET∙min∙wk-1 of 
VIPA. These levels correspond to those not meeting the 2008 DHHS recommendation (3) 
and those reporting engaging in a level of VIPA meeting the PA recommendation, 
respectively. 
 The dependent variable in this study was an elevated serum CRP concentration 
 (3 mg/L<CRP<10 mg/L). This level corresponds to the high risk CRP level as 
designated by the statement to healthcare professionals by CDC and the AHA (2). 
Participant CRP concentrations were measured using latex enhanced nephelometry on a 
Dade Behring Nephelometer II Analyzer System at the University of Washington 
Medical Center. Seattle, Washington (11).   
 Data from the 1999-2006 NHANES were analyzed to determine the odds of 
having elevated CRP concentrations by level of reported VIPA participation. The data 
were initially managed using SAS 9.2 (12). SAS was used to conduct complex variable 
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recodes and data coding validation. SAS-callable SUDAAN (13) was used to conduct the 
analysis and incorporate the sampling weights within the context of the correlated multi-
stage complex sampling design inherent to NHANES. PROC DESCRIPT was used for 
calculating age-adjusted prevalence estimates of elevated CRP for the categorical 
variables. Multivariable logistic regression models, using PROC RLOGIST, were created 
to estimate the odds ratios and 95% confidence intervals for participants who reported 
any volume of VIPA having elevated CRP. The logistic regression model adjusted for 
gender, race, smoking status, LDL-C, HDL-C, diabetes, and WC. Any participants who 
responded ‘don’t know/not sure’, refused to answer, or had missing responses for any of 
the questions or measures were excluded from the final analysis.  
 
Results 
Table 1 illustrates the prevalence estimates for elevated CRP according to sample 
characteristics.  
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Table 1. Prevalence of Elevated CRP According to Sample Characteristics: NHANES 1999-2006 
Covariates N Weighted % (SE %) 
Total 6242 29.5 (0.81) 
VIPA   
None 4297 33.2 (0.99) 
<500 MET∙min∙wk-1 873 24.1 (1.60) 
≥500 MET∙min∙wk-1 1072 20.5 (1.58) 
Age   
20-39 2107 24.0 (1.21) 
40-59 1949 31.3 (1.41) 
≥60 2186 36.0 (1.42) 
Gender   
Male 3294 25.3 (0.94) 
Female 2948 33.8 (1.09) 
Race   
non-Hispanic white 3280 28.8 (0.95) 
non-Hispanic black 1145 32.0 (1.50) 
Mexican American 1370 36.2 (1.35) 
Other 447 27.6 (2.99) 
Smoking Status   
Never Smoked 3175 27.5 (0.96) 
Former Smoker 1711 28.7 (1.93) 
Current Smoker 1356 35.0 (1.58) 
LDL-C (mg/dL)   
<160 5440 28.8 (0.74) 
≥160 
HDL-C (mg/dL) 
≥40, men; ≥50, women 
<40, men; <50, women 
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4475 
1767 
34.4 (2.57) 
 
25.3 (0.89) 
40.1 (1.77) 
Diabetes   
No 5569 28.6 (0.85) 
Yes 673 46.1 (3.89) 
Augmented WC   
No 3146 17.8 (0.85) 
Yes 3096 43.6 (1.13) 
Independent variables included vigorous intensity physical activity (VIPA), age (years), gender, race, 
smoking status, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-
C), diabetes status, and augmented waist circumference (WC) men (yes: ≥102 cm, no: <102 cm), women 
(yes: ≥88 cm, no <88 cm). 
Abbreviations: Elevated CRP, elevated C - reactive protein (>3 mg/L to ≤10 mg/L) 
 
 Age-adjusted prevalence estimate of elevated CRP concentration among U.S. 
adults meeting the study inclusion criteria was 29.5%. Prevalence estimates of elevated 
CRP increased with age (20-39 [24.0%], 40-59 [31.3%], and ≥60 years of age [36%]) and 
were found to be greater among women (33.8%), Mexican-Americans (36.2%) and non-
Hispanic blacks (32.0%). Prevalence estimates of elevated CRP were found to be higher 
in former (28.7%) and current smokers (35.0%) as well as participants with high LDL-C 
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(34.4%) and reduced HDL-C (40.1%). Prevalence estimates of elevated CRP among 
individuals according to diabetes status was 46.1% and 28.6% for those classified as 
having diabetes and not having diabetes, respectively. Prevalence estimates of elevated 
CRP increased with central adiposity, 43.6% for those classified as having an augmented 
WC compared to 17.8% for those not classified with greater levels of central adiposity.  
 Table 2 shows the results of the logistic regression analysis examining the 
associations between elevated CRP and the independent variables.  
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Table 2. Elevated C - reactive Protein and Independent Variables: NHANES 1999-2006 
Odds of Having an Elevated CRP Level 
Variable OR (95% CI) P-Value 
VIPA   
None 1.00  
<500 MET∙min∙wk-1 0.70(0.58-0.85)* <0.001 
≥500 MET∙min∙wk-1 0.66(0.53-0.82)* <0.001 
Gender   
Male 1.00  
Female 1.32(1.16-1.50)* <0.001 
Race   
non-Hispanic white 1.00  
non-Hispanic black 1.08(0.91-1.29)* 0.375 
Mexican American 1.32(1.12-1.56) 0.001 
Other 0.96(0.72-1.28) 0.794 
Smoking Status   
Never Smoked 1.00  
Former Smoker 1.19(0.98-1.45) 0.081 
Current Smoker 1.47(1.21-1.77)* <0.001 
LDL-C (mg/dL)   
<160 1.00  
≥160 1.26(1.02-1.55)* 0.036 
HDL-C (mg/dL) 
≥40, men; ≥50, women 
<40, men; <50, women 
Diabetes 
 
1.00 
1.43(1.18-1.73)* 
 
 
<0.001 
No 1.00  
Yes 1.25(1.01-1.55)* 0.037 
Augmented WC    
No 1.00  
Yes 3.29(2.86-3.80)* <0.001 
Independent variables included vigorous intensity physical activity (VIPA) (< 500 MET∙min∙wk-1 vs. none 
and ≥500 MET∙min∙wk-1 vs. none), gender (female vs. male), race ((non-Hispanic (nH) Black vs. nH White, 
Hispanic vs. nH White, and other vs. nH White)), smoking status(current vs. never and former vs. never), 
low-density lipoprotein cholesterol ≥160 mg/dL (yes vs. no), high-density lipoprotein cholesterol men (≥40 
mg/dL, yes vs. no), women (≥50 mg/dL, yes vs. no), diabetes (yes vs. no) and augmented waist 
circumference (WC) men (yes: ≥102 cm vs. no: <102 cm), women (yes: ≥88 cm vs. no: <88 cm). 
*Significant predictors (P<0.05)  
Abbreviations: Elevated CRP, C - reactive protein (>3 mg/L to ≤10 mg/L); OR, odds ratio; CI, confidence 
interval; MET, metabolic equivalent 
 
 In our initial logistic regression, a statistically non-significant increase in odds of 
having elevated CRP was observed in those 40-59 yr (P=0.220) and those ≥60 yr 
(P=0.118) when compared to those 20-39 yr (referent group). Moreover, a statistically 
significant relationship between age and elevated CRP was not revealed (P=0.257). Thus, 
the final analysis does not include age as a covariate. Final analysis revealed significantly 
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lower odds of having elevated CRP for subjects reporting insufficient VIPA (OR 0.70; 
95% CI 0.58-0.85, P=0.0004) or volumes of VIPA meeting the 2008 DHHS 
recommendation (OR 0.66; 95% CI 0.53-0.82, P=0.0003). This protective inverse 
association was independent of several metabolic risk factors, including; having an 
augmented WC, a high LDL-C level, a reduced HDL-C level, diabetes, and smoking. In 
comparison to a referent group of male participants, the odds of having an elevated CRP 
level were 32% higher in female survey participants (OR 1.32; 95% CI 1.16-1.50, 
P<0.001). When examining race with non-Hispanic whites serving as our referent, the 
odds of having elevated CRP levels were 32% higher non-Mexican Americans  (OR 1.32; 
95% CI 1.12-1.56, P=0.001), while an increased odds of having elevated CRP in non-
Hispanic blacks was not statistically significant (P=0.375). The odds of having an 
elevated CRP level were 47% higher for current smokers when compared to a referent 
group reporting never smoking (P<0.001). This analysis also revealed significantly 
higher odds of having elevated CRP for participants with LDL-C concentrations ≥160 
mg/dL (OR 1.26; 95% CI 1.02-1.55, P=0.036) or reduced HDL-C concentrations (OR 
1.43; 95% CI 1.18-1.73, P<0.001). The odds of those classified as having diabetes having 
elevated CRP were significantly higher (OR 1.25; 95% CI 1.01-1.55, P=0.037) when 
compared to those classified as not having diabetes. Lastly, the odds of those with an 
augmented WC having an elevated CRP level were approximately 3.3 times higher (OR 
3.29; 95% CI 2.86-3.80, P<0.001) compared to a referent group of survey participants not 
classified as having an augmented WC. 
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Discussion 
The current PA guidelines for U.S. adults (3) recommend a minimum of 150 minutes of 
MIPA or 75 minutes of VIPA per week. In this nationally representative sample of U.S. 
adults, reporting any volume (MET∙min∙wk-1) of VIPA was associated with a significant 
decrease in odds of having an elevated CRP level. Furthermore, our findings illustrate a 
statistically significant inverse dose-response relationship between reported VIPA and 
having an elevated CRP level. Interestingly, our analysis revealed significantly lower 
odds of having an elevated CRP level for those reporting volumes of VIPA that met the 
2008 DHHS recommendation as well as for those reporting insufficient volumes. In 
contrast to the findings of other cross-sectional analyses that investigated high levels of 
physical activity participation (min/wk) (14,15), these associations remained statistically 
significant following adjustments for adiposity.  
 Our findings add to the current evidence demonstrating an inverse relationship 
between PA and CRP in U.S. adults (16,17) independent of other major risk factors (2).  
In an analysis of 13,748 adult participants of the Third NHANES, reporting vigorous 
leisure-time physical activity was associated with 47% lower odds of having an elevated 
CRP level when compared to a sedentary referent group (16). Inverse associations 
between activities of vigorous intensity and CRP have also been reported when 
comparing the CRP levels of non- and infrequent exercisers (0 to 11 times/mo) to those 
who engage in regular exercise (≥12 times/mo) (17). Among 4,072 adult participants in 
the Third NHANES, analysis by King et al.(17) revealed significantly (P<0.05) lower 
likelihood of elevated CRP among those reporting regular participation in jogging, 
swimming, cycling, aerobic dancing, calisthenics, and weight lifting when using non and 
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infrequent exercisers (0-11 times/mo) as the referent group. Following adjustment for 
age, race or ethnicity, gender, body mass index, smoking, and health status, the 
association remained significant in those reporting jogging (OR 0.33; 95% CI 0.14–0.78, 
P<0.05) or aerobic dancing (OR 0.31; 95% CI 0.13–0.78, P<0.05) 12 or more times/mo 
when compared to a referent group of non and infrequent exercisers. The results of the 
aforementioned studies, as well as those from our study, suggest that the observed 
reduction in odds of having elevated CRP may be associated with the intensity of PA. 
Furthermore, recent research using data from the 1999-2004 NHANES has revealed a 
significant (P<0.01) inverse dose-response relationship between VIPA and metabolic 
syndrome (18), which is known to be associated with elevated CRP levels (19).   
 Our findings also support those reported in prospective studies revealing 
statistically significant reductions in CRP levels for increased levels of moderate to 
vigorous PA participation. In a 12 week study that implemented a combination of aerobic 
and resistance exercise a 58% reduction in CRP levels was reported (20).  Similarly, 
investigators have reported a 60% reduction in the CRP levels of participants in a 15-
week trial involving a combination of endurance and resistance exercise (21). The current 
findings add to previous work and illustrate the importance of examining the 
relationships between PA, the volume and intensity of the PA, and other factors that are 
associated with CRP levels. 
 The strengths of this study include the use of a large representative sample of U.S. 
adults and the use of objectively measured markers of cardio-metabolic risk. The 
limitations include those inherent to utilization of cross-sectional data, which does not 
allow the ability to make causal inferences about the relationship between VIPA and 
110 
 
CRP. The estimations of VIPA participation were derived from self-report data, which 
may have bias due to social desirability effect and recall. These factors may have resulted 
in the under or over estimation of the reported associations. 
 
Conclusions 
Our findings suggest that a statistically significant inverse dose-response relationship 
exists between self-reported volumes of VIPA and having an elevated CRP level. These 
results also suggest that this relationship is independent of central adiposity, a known 
mediator in the relationship between PA and CRP. Future studies should examine the 
associations among objectively measured VIPA and elevated CRP levels. 
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